GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf16
|
ENSRNOG00000033694 | Kruppel-like factor 16 |
Sp8
|
ENSRNOG00000005943 | Sp8 transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Klf16 | rn6_v1_chr7_+_12006710_12006710 | -0.44 | 6.7e-17 | Click! |
Sp8 | rn6_v1_chr6_+_146784915_146784915 | -0.22 | 6.7e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_36320461 | 185.52 |
ENSRNOT00000023659
|
Srd5a1
|
steroid 5 alpha-reductase 1 |
chr13_-_50499060 | 156.41 |
ENSRNOT00000065347
ENSRNOT00000076924 |
Etnk2
|
ethanolamine kinase 2 |
chr8_-_22937909 | 131.40 |
ENSRNOT00000015684
|
Tmem205
|
transmembrane protein 205 |
chr7_-_12246729 | 130.00 |
ENSRNOT00000044030
|
Reep6
|
receptor accessory protein 6 |
chrX_-_54303729 | 115.47 |
ENSRNOT00000087919
ENSRNOT00000064340 ENSRNOT00000051249 ENSRNOT00000087547 |
Gk
|
glycerol kinase |
chr16_-_32868680 | 113.82 |
ENSRNOT00000015974
ENSRNOT00000082392 |
Aadat
|
aminoadipate aminotransferase |
chr6_-_108167185 | 110.45 |
ENSRNOT00000015545
|
Aldh6a1
|
aldehyde dehydrogenase 6 family, member A1 |
chr1_-_80666566 | 107.61 |
ENSRNOT00000082125
ENSRNOT00000025388 |
Nectin2
|
nectin cell adhesion molecule 2 |
chr3_-_176144531 | 102.70 |
ENSRNOT00000082266
|
Tcfl5
|
transcription factor like 5 |
chr1_-_80599572 | 99.23 |
ENSRNOT00000024832
|
Apoc4
|
apolipoprotein C4 |
chr3_+_151032952 | 95.88 |
ENSRNOT00000064013
|
Acss2
|
acyl-CoA synthetase short-chain family member 2 |
chr3_-_10375826 | 93.96 |
ENSRNOT00000093365
|
Ass1
|
argininosuccinate synthase 1 |
chr12_-_22194287 | 93.33 |
ENSRNOT00000082895
ENSRNOT00000001905 |
Tfr2
|
transferrin receptor 2 |
chr7_+_12247498 | 90.64 |
ENSRNOT00000022358
|
Pcsk4
|
proprotein convertase subtilisin/kexin type 4 |
chr7_+_12043794 | 85.69 |
ENSRNOT00000039813
|
Atp8b3
|
ATPase phospholipid transporting 8B3 |
chr7_-_119623072 | 85.28 |
ENSRNOT00000050511
|
Tst
|
thiosulfate sulfurtransferase |
chr5_+_154598758 | 78.95 |
ENSRNOT00000015776
|
Tcea3
|
transcription elongation factor A3 |
chr7_+_28066635 | 78.67 |
ENSRNOT00000005844
|
Pah
|
phenylalanine hydroxylase |
chr12_+_12227010 | 77.66 |
ENSRNOT00000060843
ENSRNOT00000092610 |
Baiap2l1
|
BAI1-associated protein 2-like 1 |
chr8_-_116422366 | 76.00 |
ENSRNOT00000023623
|
Slc38a3
|
solute carrier family 38, member 3 |
chr16_+_20521956 | 75.84 |
ENSRNOT00000026597
|
Pgpep1
|
pyroglutamyl-peptidase I |
chr18_-_51651267 | 75.51 |
ENSRNOT00000020325
|
Aldh7a1
|
aldehyde dehydrogenase 7 family, member A1 |
chr1_-_256813711 | 75.04 |
ENSRNOT00000021055
|
Rbp4
|
retinol binding protein 4 |
chr17_+_76306585 | 74.41 |
ENSRNOT00000065978
|
Dhtkd1
|
dehydrogenase E1 and transketolase domain containing 1 |
chr4_+_153217782 | 74.29 |
ENSRNOT00000015499
|
Cecr2
|
CECR2, histone acetyl-lysine reader |
chr15_-_84748525 | 73.95 |
ENSRNOT00000090009
|
Klf12
|
Kruppel-like factor 12 |
chr2_-_23256158 | 73.61 |
ENSRNOT00000015336
|
Bhmt
|
betaine-homocysteine S-methyltransferase |
chr10_+_89376530 | 72.35 |
ENSRNOT00000028089
|
Rnd2
|
Rho family GTPase 2 |
chr1_+_219759183 | 69.29 |
ENSRNOT00000026316
|
Pc
|
pyruvate carboxylase |
chr15_-_19733967 | 69.08 |
ENSRNOT00000012036
|
Gnpnat1
|
glucosamine-phosphate N-acetyltransferase 1 |
chr2_+_21931493 | 68.11 |
ENSRNOT00000018259
|
Dhfr
|
dihydrofolate reductase |
chr6_+_127400585 | 67.86 |
ENSRNOT00000087429
|
Ppp4r4
|
protein phosphatase 4, regulatory subunit 4 |
chr1_-_80609836 | 66.96 |
ENSRNOT00000091647
ENSRNOT00000046169 |
Apoc1
|
apolipoprotein C1 |
chr17_-_417480 | 66.63 |
ENSRNOT00000023685
|
Fbp1
|
fructose-bisphosphatase 1 |
chr1_-_216663720 | 66.45 |
ENSRNOT00000078944
ENSRNOT00000077409 |
Cdkn1c
|
cyclin-dependent kinase inhibitor 1C |
chr7_+_2605719 | 65.25 |
ENSRNOT00000018737
|
Gls2
|
glutaminase 2 |
chr12_+_19599834 | 65.08 |
ENSRNOT00000092039
ENSRNOT00000042006 |
Stag3
|
stromal antigen 3 |
chr19_+_23389375 | 64.62 |
ENSRNOT00000018629
|
Sall1
|
spalt-like transcription factor 1 |
chr5_-_134207847 | 64.56 |
ENSRNOT00000083686
ENSRNOT00000088209 ENSRNOT00000051252 |
Cyp4a2
|
cytochrome P450, family 4, subfamily a, polypeptide 2 |
chr13_+_85580828 | 63.79 |
ENSRNOT00000005611
|
Aldh9a1
|
aldehyde dehydrogenase 9 family, member A1 |
chr5_+_126164674 | 62.57 |
ENSRNOT00000009402
|
Dhcr24
|
24-dehydrocholesterol reductase |
chr1_+_217018916 | 62.54 |
ENSRNOT00000028195
ENSRNOT00000078979 |
Dhcr7
|
7-dehydrocholesterol reductase |
chr6_-_127653124 | 61.82 |
ENSRNOT00000047324
|
Serpina11
|
serpin family A member 11 |
chr3_-_138116664 | 60.89 |
ENSRNOT00000055602
|
Rrbp1
|
ribosome binding protein 1 |
chr8_+_22937916 | 60.86 |
ENSRNOT00000088255
ENSRNOT00000049993 |
Ccdc159
|
coiled-coil domain containing 159 |
chr20_-_14193690 | 60.70 |
ENSRNOT00000058237
|
Upb1
|
beta-ureidopropionase 1 |
chr19_-_37916813 | 60.46 |
ENSRNOT00000026585
|
Lcat
|
lecithin cholesterol acyltransferase |
chr2_-_264293010 | 59.52 |
ENSRNOT00000082532
ENSRNOT00000067843 |
LOC103691744
|
cystathionine gamma-lyase |
chr1_-_214202853 | 59.43 |
ENSRNOT00000022954
|
Lmntd2
|
lamin tail domain containing 2 |
chr10_+_109665682 | 59.18 |
ENSRNOT00000054963
|
Slc25a10
|
solute carrier family 25 member 10 |
chrY_-_1403422 | 58.53 |
ENSRNOT00000093067
|
Usp9y
|
ubiquitin specific peptidase 9, Y-linked |
chr7_+_26375866 | 57.86 |
ENSRNOT00000059639
|
Aldh1l2
|
aldehyde dehydrogenase 1 family, member L2 |
chr1_+_243477493 | 57.66 |
ENSRNOT00000021779
ENSRNOT00000085356 |
Dmrt1
|
doublesex and mab-3 related transcription factor 1 |
chr5_+_60528997 | 56.74 |
ENSRNOT00000051445
|
Grhpr
|
glyoxylate and hydroxypyruvate reductase |
chr10_+_4951557 | 56.68 |
ENSRNOT00000003451
|
Prm3
|
protamine 3 |
chr20_+_13799102 | 54.93 |
ENSRNOT00000001669
|
Gstt1
|
glutathione S-transferase theta 1 |
chr1_-_78573374 | 54.63 |
ENSRNOT00000090519
|
Arhgap35
|
Rho GTPase activating protein 35 |
chr6_+_111176798 | 54.44 |
ENSRNOT00000072215
|
Gstz1
|
glutathione S-transferase zeta 1 |
chr19_+_26106838 | 54.20 |
ENSRNOT00000035987
|
Hook2
|
hook microtubule-tethering protein 2 |
chr7_+_126619196 | 54.20 |
ENSRNOT00000030082
|
Ppara
|
peroxisome proliferator activated receptor alpha |
chr5_+_154552195 | 54.15 |
ENSRNOT00000072864
|
Asap3
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 |
chr15_-_3435888 | 54.12 |
ENSRNOT00000016709
|
Adk
|
adenosine kinase |
chr4_+_117679342 | 53.45 |
ENSRNOT00000021272
|
Figla
|
folliculogenesis specific bHLH transcription factor |
chr12_-_21832813 | 52.88 |
ENSRNOT00000075280
|
Cldn3
|
claudin 3 |
chr20_+_28989491 | 52.85 |
ENSRNOT00000074524
|
Pla2g12b
|
phospholipase A2, group XIIB |
chr3_-_5481144 | 52.43 |
ENSRNOT00000078429
|
Surf4
|
surfeit 4 |
chr2_+_78825074 | 52.39 |
ENSRNOT00000032027
|
March11
|
membrane associated ring-CH-type finger 11 |
chr2_+_77868412 | 51.43 |
ENSRNOT00000065897
ENSRNOT00000014022 |
Myo10
|
myosin X |
chr8_+_64364741 | 51.39 |
ENSRNOT00000082840
|
Celf6
|
CUGBP, Elav-like family member 6 |
chr6_-_94834908 | 51.31 |
ENSRNOT00000006284
|
L3hypdh
|
trans-L-3-hydroxyproline dehydratase |
chr3_+_5481522 | 51.25 |
ENSRNOT00000031316
|
Stkld1
|
serine/threonine kinase-like domain containing 1 |
chrX_+_123205869 | 51.09 |
ENSRNOT00000017101
ENSRNOT00000079231 |
Pgrmc1
|
progesterone receptor membrane component 1 |
chr3_-_62524996 | 50.70 |
ENSRNOT00000002114
|
Nfe2l2
|
nuclear factor, erythroid 2-like 2 |
chr1_-_247476827 | 50.68 |
ENSRNOT00000021298
|
Insl6
|
insulin-like 6 |
chr1_-_101210675 | 50.65 |
ENSRNOT00000028082
|
Dkkl1
|
dickkopf like acrosomal protein 1 |
chr17_+_21382455 | 50.54 |
ENSRNOT00000019756
|
Elovl2
|
ELOVL fatty acid elongase 2 |
chr2_-_185168476 | 50.10 |
ENSRNOT00000093447
|
Fam160a1
|
family with sequence similarity 160, member A1 |
chr8_+_127735258 | 49.93 |
ENSRNOT00000015888
|
Vill
|
villin-like |
chr14_+_70164650 | 49.91 |
ENSRNOT00000004385
|
Qdpr
|
quinoid dihydropteridine reductase |
chr2_-_210703606 | 49.89 |
ENSRNOT00000077563
|
Gstm6l
|
glutathione S-transferase, mu 6-like |
chrY_+_422855 | 49.36 |
ENSRNOT00000092178
|
Uba1y
|
ubiquitin-activating enzyme, Chr Y |
chr1_+_98440186 | 49.34 |
ENSRNOT00000024150
|
Iglon5
|
IgLON family member 5 |
chr15_-_41890716 | 48.97 |
ENSRNOT00000020419
|
Spryd7
|
SPRY domain containing 7 |
chr7_-_34406318 | 48.83 |
ENSRNOT00000007331
|
Amdhd1
|
amidohydrolase domain containing 1 |
chr5_+_136112417 | 48.82 |
ENSRNOT00000025990
|
Tmem53
|
transmembrane protein 53 |
chr7_+_12314848 | 48.77 |
ENSRNOT00000028969
|
Gamt
|
guanidinoacetate N-methyltransferase |
chr10_-_103826448 | 48.71 |
ENSRNOT00000085636
|
Fdxr
|
ferredoxin reductase |
chr19_-_22632071 | 48.51 |
ENSRNOT00000077275
|
Gpt2
|
glutamic--pyruvic transaminase 2 |
chr19_-_37370429 | 48.34 |
ENSRNOT00000022497
|
Kctd19
|
potassium channel tetramerization domain containing 19 |
chr1_-_273758247 | 47.38 |
ENSRNOT00000033148
|
Xpnpep1
|
X-prolyl aminopeptidase 1 |
chr1_+_82169620 | 47.30 |
ENSRNOT00000088955
ENSRNOT00000068251 |
Prr19
|
proline rich 19 |
chrX_+_69730242 | 46.70 |
ENSRNOT00000075980
ENSRNOT00000076425 |
Eda
|
ectodysplasin-A |
chr1_-_263803150 | 46.51 |
ENSRNOT00000017840
|
Cyp2c23
|
cytochrome P450, family 2, subfamily c, polypeptide 23 |
chr6_-_128567198 | 46.49 |
ENSRNOT00000065529
|
Clmn
|
calmin |
chr7_+_34326087 | 46.26 |
ENSRNOT00000006971
|
Hal
|
histidine ammonia lyase |
chr17_+_76002275 | 46.15 |
ENSRNOT00000092665
ENSRNOT00000086701 |
Echdc3
|
enoyl CoA hydratase domain containing 3 |
chr14_+_85113578 | 46.04 |
ENSRNOT00000011158
|
Nipsnap1
|
nipsnap homolog 1 |
chr10_+_56546710 | 46.04 |
ENSRNOT00000023003
|
Ybx2
|
Y box binding protein 2 |
chr18_+_79773608 | 45.79 |
ENSRNOT00000088484
|
Zfp516
|
zinc finger protein 516 |
chr2_-_21931720 | 45.61 |
ENSRNOT00000018449
|
Msh3
|
mutS homolog 3 |
chr2_-_23289266 | 45.50 |
ENSRNOT00000061708
|
Bhmt2
|
betaine-homocysteine S-methyltransferase 2 |
chr16_-_20641908 | 45.28 |
ENSRNOT00000026846
|
Ell
|
elongation factor for RNA polymerase II |
chr8_-_114853103 | 45.13 |
ENSRNOT00000074595
|
Glyctk
|
glycerate kinase |
chr9_-_61974898 | 45.12 |
ENSRNOT00000091519
|
Boll
|
boule homolog, RNA binding protein |
chr9_-_64573076 | 44.52 |
ENSRNOT00000084658
|
LOC108348134
|
protein boule-like |
chr3_+_170354141 | 44.49 |
ENSRNOT00000005901
|
Fam210b
|
family with sequence similarity 210, member B |
chr18_-_28454756 | 44.42 |
ENSRNOT00000040091
|
Spata24
|
spermatogenesis associated 24 |
chr8_+_81766041 | 44.26 |
ENSRNOT00000032280
|
Onecut1
|
one cut homeobox 1 |
chr10_-_61772250 | 44.13 |
ENSRNOT00000092338
ENSRNOT00000085394 ENSRNOT00000046110 |
Srr
|
serine racemase |
chr1_-_226657408 | 44.13 |
ENSRNOT00000028102
|
Tkfc
|
triokinase and FMN cyclase |
chr16_+_47717951 | 43.99 |
ENSRNOT00000018689
|
Ing2
|
inhibitor of growth family, member 2 |
chr1_+_226687258 | 43.91 |
ENSRNOT00000079679
|
Vwce
|
von Willebrand factor C and EGF domains |
chr10_+_56445647 | 43.78 |
ENSRNOT00000056870
|
Tmem256
|
transmembrane protein 256 |
chr8_-_94368834 | 43.54 |
ENSRNOT00000078977
|
Me1
|
malic enzyme 1 |
chr2_-_260148589 | 43.53 |
ENSRNOT00000013238
|
Acadm
|
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
chr18_-_61707307 | 43.47 |
ENSRNOT00000085784
ENSRNOT00000032047 |
Lman1
|
lectin, mannose-binding, 1 |
chr1_-_107373807 | 43.21 |
ENSRNOT00000056024
|
Svip
|
small VCP interacting protein |
chr14_+_115166416 | 43.12 |
ENSRNOT00000088916
ENSRNOT00000078329 |
Psme4
|
proteasome activator subunit 4 |
chr14_-_16979760 | 43.01 |
ENSRNOT00000003020
|
Stbd1
|
starch binding domain 1 |
chr1_+_166893734 | 43.00 |
ENSRNOT00000026702
|
Phox2a
|
paired-like homeobox 2a |
chr2_-_53413638 | 42.80 |
ENSRNOT00000021081
|
Ghr
|
growth hormone receptor |
chr11_+_30363280 | 42.50 |
ENSRNOT00000002885
|
Sod1
|
superoxide dismutase 1, soluble |
chr6_-_7058314 | 42.49 |
ENSRNOT00000045996
|
Haao
|
3-hydroxyanthranilate 3,4-dioxygenase |
chr11_+_7210209 | 42.38 |
ENSRNOT00000076695
|
Gbe1
|
1,4-alpha-glucan branching enzyme 1 |
chr1_-_273758442 | 41.94 |
ENSRNOT00000088016
|
Xpnpep1
|
X-prolyl aminopeptidase 1 |
chr1_+_216677373 | 41.85 |
ENSRNOT00000027925
|
Slc22a18
|
solute carrier family 22, member 18 |
chr5_-_164971903 | 41.75 |
ENSRNOT00000067059
|
Fbxo44
|
F-box protein 44 |
chr9_+_53906073 | 41.60 |
ENSRNOT00000017813
|
Nab1
|
Ngfi-A binding protein 1 |
chr16_-_7026540 | 41.56 |
ENSRNOT00000051751
|
Itih1
|
inter-alpha trypsin inhibitor, heavy chain 1 |
chr9_-_16612136 | 41.44 |
ENSRNOT00000023495
|
Mea1
|
male-enhanced antigen 1 |
chr15_+_46008613 | 41.41 |
ENSRNOT00000066864
ENSRNOT00000080537 |
Wdfy2
|
WD repeat and FYVE domain containing 2 |
chr15_-_46367302 | 41.36 |
ENSRNOT00000032089
|
Fdft1
|
farnesyl diphosphate farnesyl transferase 1 |
chr5_-_169167831 | 41.32 |
ENSRNOT00000012407
|
Phf13
|
PHD finger protein 13 |
chr8_-_50526843 | 41.03 |
ENSRNOT00000092188
|
AABR07070085.1
|
|
chr1_-_92069160 | 41.03 |
ENSRNOT00000039115
|
Dpy19l3
|
dpy-19-like 3 (C. elegans) |
chrX_+_157095937 | 40.92 |
ENSRNOT00000091792
|
Bcap31
|
B-cell receptor-associated protein 31 |
chr1_-_163328591 | 40.89 |
ENSRNOT00000034843
|
Tsku
|
tsukushi, small leucine rich proteoglycan |
chr19_-_49532811 | 40.67 |
ENSRNOT00000015967
|
Gcsh
|
glycine cleavage system protein H |
chr2_+_23289374 | 40.57 |
ENSRNOT00000090666
ENSRNOT00000032783 |
Dmgdh
|
dimethylglycine dehydrogenase |
chr5_+_61565064 | 40.57 |
ENSRNOT00000090186
|
Tdrd7
|
tudor domain containing 7 |
chr8_-_47529689 | 40.41 |
ENSRNOT00000012826
|
Oaf
|
out at first homolog |
chr11_+_87204175 | 40.34 |
ENSRNOT00000000306
|
Slc25a1
|
solute carrier family 25 member 1 |
chr17_+_77167740 | 40.18 |
ENSRNOT00000042881
|
Optn
|
optineurin |
chr2_+_195617021 | 40.15 |
ENSRNOT00000067042
ENSRNOT00000036656 |
Rorc
Lingo4
|
RAR-related orphan receptor C leucine rich repeat and Ig domain containing 4 |
chr9_-_64573660 | 39.95 |
ENSRNOT00000021299
|
LOC108348134
|
protein boule-like |
chr2_-_128002005 | 39.84 |
ENSRNOT00000018796
|
Pgrmc2
|
progesterone receptor membrane component 2 |
chr9_+_95501778 | 39.77 |
ENSRNOT00000086805
|
Spp2
|
secreted phosphoprotein 2 |
chr4_-_157009674 | 39.56 |
ENSRNOT00000071625
|
Pex5
|
peroxisomal biogenesis factor 5 |
chr9_-_92435363 | 39.47 |
ENSRNOT00000093735
ENSRNOT00000022822 ENSRNOT00000093245 |
Trip12
|
thyroid hormone receptor interactor 12 |
chr19_+_15195565 | 39.33 |
ENSRNOT00000090865
ENSRNOT00000078874 |
Ces1d
|
carboxylesterase 1D |
chr8_-_40078165 | 39.27 |
ENSRNOT00000014866
|
Spa17
|
sperm autoantigenic protein 17 |
chr1_+_201981357 | 39.19 |
ENSRNOT00000027999
|
Acadsb
|
acyl-CoA dehydrogenase, short/branched chain |
chr1_-_80615704 | 38.63 |
ENSRNOT00000041891
|
Apoe
|
apolipoprotein E |
chr19_+_15033108 | 38.62 |
ENSRNOT00000021812
|
Ces1d
|
carboxylesterase 1D |
chr5_-_127523089 | 38.57 |
ENSRNOT00000016954
|
Cpt2
|
carnitine palmitoyltransferase 2 |
chr7_+_94795214 | 38.51 |
ENSRNOT00000005722
|
Deptor
|
DEP domain containing MTOR-interacting protein |
chr5_+_9279970 | 38.43 |
ENSRNOT00000067977
|
Mybl1
|
myeloblastosis oncogene-like 1 |
chr16_-_81797815 | 38.38 |
ENSRNOT00000026666
|
Proz
|
protein Z, vitamin K-dependent plasma glycoprotein |
chr18_-_15167311 | 38.36 |
ENSRNOT00000021061
|
Rnf138
|
ring finger protein 138 |
chr9_-_61975640 | 38.36 |
ENSRNOT00000085744
|
Boll
|
boule homolog, RNA binding protein |
chr8_+_106449321 | 38.34 |
ENSRNOT00000018622
|
Rbp1
|
retinol binding protein 1 |
chr10_+_83954279 | 38.18 |
ENSRNOT00000006594
|
Ttll6
|
tubulin tyrosine ligase like 6 |
chr4_+_27175243 | 38.12 |
ENSRNOT00000009985
|
Cyp51
|
cytochrome P450, family 51 |
chr1_+_218632764 | 38.11 |
ENSRNOT00000019861
|
Tesmin
|
testis expressed metallothionein like protein |
chr7_-_11186130 | 38.04 |
ENSRNOT00000075038
|
Smim24
|
small integral membrane protein 24 |
chr14_+_44479614 | 37.80 |
ENSRNOT00000003691
|
Ugdh
|
UDP-glucose 6-dehydrogenase |
chr10_+_14240219 | 37.57 |
ENSRNOT00000020233
|
Igfals
|
insulin-like growth factor binding protein, acid labile subunit |
chr19_+_15294248 | 37.43 |
ENSRNOT00000024622
|
Ces1f
|
carboxylesterase 1F |
chr12_+_15890170 | 37.43 |
ENSRNOT00000001654
|
Gna12
|
G protein subunit alpha 12 |
chr19_+_25983169 | 37.42 |
ENSRNOT00000004404
|
Syce2
|
synaptonemal complex central element protein 2 |
chr3_+_151553578 | 37.39 |
ENSRNOT00000045484
|
Ergic3
|
ERGIC and golgi 3 |
chr5_-_78379346 | 37.35 |
ENSRNOT00000020625
|
Alad
|
aminolevulinate dehydratase |
chr13_-_37287458 | 37.31 |
ENSRNOT00000003391
|
Insig2
|
insulin induced gene 2 |
chr18_+_59830363 | 37.26 |
ENSRNOT00000082650
ENSRNOT00000078378 |
Onecut2
|
one cut domain, family member 2 |
chr16_-_54513349 | 37.25 |
ENSRNOT00000014809
ENSRNOT00000015127 |
Slc7a2
|
solute carrier family 7 member 2 |
chr5_-_136112344 | 37.25 |
ENSRNOT00000050195
|
RGD1563714
|
RGD1563714 |
chr1_+_198690794 | 37.17 |
ENSRNOT00000023999
|
Zfp771
|
zinc finger protein 771 |
chr4_+_121612332 | 37.16 |
ENSRNOT00000077374
ENSRNOT00000084494 |
Txnrd3
|
thioredoxin reductase 3 |
chr10_-_13580821 | 37.05 |
ENSRNOT00000009735
|
Ntn3
|
netrin 3 |
chr1_+_40086470 | 36.81 |
ENSRNOT00000021895
|
Iyd
|
iodotyrosine deiodinase |
chr3_+_134413170 | 36.70 |
ENSRNOT00000074338
|
AABR07054000.1
|
|
chr3_+_95233874 | 36.69 |
ENSRNOT00000079743
|
LOC691083
|
hypothetical protein LOC691083 |
chrX_-_33665821 | 36.69 |
ENSRNOT00000066676
|
Rbbp7
|
RB binding protein 7, chromatin remodeling factor |
chr9_-_80295446 | 36.62 |
ENSRNOT00000023769
|
Tnp1
|
transition protein 1 |
chr1_+_72636959 | 36.40 |
ENSRNOT00000023489
|
Il11
|
interleukin 11 |
chr17_+_18029124 | 36.38 |
ENSRNOT00000022085
|
Tpmt
|
thiopurine S-methyltransferase |
chr16_+_74865516 | 36.33 |
ENSRNOT00000058072
|
Atp7b
|
ATPase copper transporting beta |
chr12_+_16913312 | 36.27 |
ENSRNOT00000001718
|
Tmem184a
|
transmembrane protein 184A |
chr6_+_37144787 | 36.20 |
ENSRNOT00000075503
|
Rad51ap2
|
RAD51 associated protein 2 |
chr17_+_78817529 | 36.03 |
ENSRNOT00000021918
|
Meig1
|
meiosis/spermiogenesis associated 1 |
chr19_+_58746313 | 35.88 |
ENSRNOT00000026986
|
Map3k21
|
mitogen-activated protein kinase kinase kinase 21 |
chr6_+_128973956 | 35.88 |
ENSRNOT00000075399
|
Fam181a
|
family with sequence similarity 181, member A |
chr8_-_27852996 | 35.86 |
ENSRNOT00000037790
|
Glb1l2
|
galactosidase, beta 1-like 2 |
chr16_-_81834945 | 35.79 |
ENSRNOT00000037806
|
F7
|
coagulation factor VII |
chrX_+_71272042 | 35.48 |
ENSRNOT00000076034
ENSRNOT00000076816 |
Gjb1
|
gap junction protein, beta 1 |
chr9_+_112293388 | 35.39 |
ENSRNOT00000020767
|
Man2a1
|
mannosidase, alpha, class 2A, member 1 |
chr12_+_36734372 | 35.36 |
ENSRNOT00000001301
|
Scarb1
|
scavenger receptor class B, member 1 |
chr3_-_94686989 | 35.28 |
ENSRNOT00000016677
|
Depdc7
|
DEP domain containing 7 |
chr10_+_103972888 | 35.27 |
ENSRNOT00000067838
|
Kctd2
|
potassium channel tetramerization domain containing 2 |
chr10_-_104748003 | 34.98 |
ENSRNOT00000042372
ENSRNOT00000046754 |
Acox1
|
acyl-CoA oxidase 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
51.5 | 154.4 | GO:0006574 | valine catabolic process(GO:0006574) |
47.6 | 142.7 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
44.8 | 134.3 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
41.7 | 125.1 | GO:0000053 | argininosuccinate metabolic process(GO:0000053) |
38.1 | 114.2 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
37.8 | 113.4 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
37.6 | 112.8 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
35.6 | 106.7 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
34.6 | 276.8 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
31.7 | 95.1 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) formamide metabolic process(GO:0043606) |
31.1 | 93.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
29.3 | 117.2 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
28.9 | 86.8 | GO:0009397 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
28.5 | 85.6 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
28.4 | 85.3 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
27.5 | 109.8 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
26.0 | 78.1 | GO:0046865 | isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
26.0 | 78.0 | GO:0019541 | acetate metabolic process(GO:0006083) propionate metabolic process(GO:0019541) |
25.1 | 75.3 | GO:1902024 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
24.9 | 99.6 | GO:0048252 | lauric acid metabolic process(GO:0048252) |
24.8 | 99.0 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
24.7 | 74.2 | GO:0071422 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
24.0 | 96.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
23.9 | 143.6 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
23.1 | 185.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
22.5 | 67.6 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
22.3 | 22.3 | GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process(GO:0032805) |
22.1 | 66.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
21.8 | 65.3 | GO:0009751 | response to salicylic acid(GO:0009751) |
20.5 | 82.2 | GO:0019483 | beta-alanine biosynthetic process(GO:0019483) |
20.2 | 40.3 | GO:0015746 | citrate transport(GO:0015746) |
19.9 | 39.9 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
19.7 | 19.7 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
19.6 | 78.2 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
19.1 | 57.2 | GO:1905225 | response to thyrotropin-releasing hormone(GO:1905225) |
18.3 | 55.0 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
17.2 | 51.6 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
17.2 | 103.1 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
16.6 | 16.6 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
16.6 | 49.7 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
16.4 | 131.2 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
15.7 | 62.7 | GO:0097069 | cellular response to thyroxine stimulus(GO:0097069) |
15.7 | 78.4 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
15.5 | 108.8 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
15.3 | 45.8 | GO:0089718 | amino acid import across plasma membrane(GO:0089718) |
15.2 | 15.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
15.1 | 60.6 | GO:0035565 | regulation of pronephros size(GO:0035565) |
14.9 | 29.7 | GO:0016107 | sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
14.8 | 44.5 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
14.8 | 44.3 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
14.7 | 44.1 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
14.6 | 14.6 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
14.6 | 43.9 | GO:0007308 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
14.6 | 218.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
14.6 | 58.3 | GO:0018992 | germ-line sex determination(GO:0018992) |
14.4 | 57.8 | GO:0015879 | carnitine transport(GO:0015879) |
14.0 | 56.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
14.0 | 42.0 | GO:0021558 | trochlear nerve development(GO:0021558) |
13.9 | 13.9 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
13.9 | 69.5 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
13.9 | 41.6 | GO:0010133 | proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
13.8 | 41.3 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
13.8 | 55.0 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
13.7 | 41.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
13.7 | 27.4 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
13.7 | 54.6 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
13.4 | 40.3 | GO:0006565 | L-serine catabolic process(GO:0006565) |
13.4 | 215.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
13.4 | 26.7 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) |
13.3 | 40.0 | GO:0030091 | protein repair(GO:0030091) |
13.3 | 39.8 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
13.2 | 39.6 | GO:0036166 | phenotypic switching(GO:0036166) |
13.0 | 38.9 | GO:0098749 | cerebellar neuron development(GO:0098749) |
12.9 | 51.7 | GO:1990402 | embryonic liver development(GO:1990402) |
12.8 | 38.5 | GO:0021539 | subthalamus development(GO:0021539) |
12.7 | 12.7 | GO:0002930 | trabecular meshwork development(GO:0002930) |
12.6 | 25.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
12.3 | 36.8 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
12.2 | 48.8 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
12.2 | 73.2 | GO:0070541 | response to platinum ion(GO:0070541) |
12.0 | 35.9 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
11.8 | 35.5 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
11.4 | 11.4 | GO:0006538 | glutamate catabolic process(GO:0006538) |
11.4 | 45.4 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
11.3 | 45.1 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
11.2 | 44.7 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
11.0 | 44.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
11.0 | 32.9 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
10.9 | 32.8 | GO:0006059 | hexitol metabolic process(GO:0006059) |
10.9 | 32.8 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
10.9 | 65.6 | GO:0006069 | ethanol oxidation(GO:0006069) |
10.9 | 54.3 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
10.8 | 75.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
10.7 | 21.5 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
10.6 | 10.6 | GO:0006553 | lysine metabolic process(GO:0006553) |
10.6 | 31.7 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
10.5 | 21.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
10.5 | 73.4 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
10.4 | 41.7 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
10.4 | 20.8 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
10.4 | 41.5 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
10.2 | 30.5 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
10.1 | 10.1 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
10.1 | 50.6 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
10.0 | 39.8 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) activation of JAK2 kinase activity(GO:0042977) negative regulation of activation of JAK2 kinase activity(GO:1902569) |
9.8 | 39.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
9.7 | 9.7 | GO:0009216 | purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) |
9.7 | 38.8 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
9.7 | 96.9 | GO:0015886 | heme transport(GO:0015886) |
9.6 | 9.6 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
9.6 | 67.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
9.6 | 28.7 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
9.6 | 19.1 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
9.5 | 19.0 | GO:0006548 | histidine catabolic process(GO:0006548) |
9.4 | 18.9 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
9.4 | 328.2 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
9.4 | 56.2 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
9.4 | 28.1 | GO:0070370 | cellular heat acclimation(GO:0070370) |
9.3 | 56.0 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
9.3 | 18.7 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
9.3 | 37.2 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
9.3 | 27.8 | GO:0060061 | Spemann organizer formation(GO:0060061) |
9.3 | 37.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
9.3 | 27.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
9.2 | 27.6 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
9.1 | 45.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
9.1 | 45.6 | GO:0030070 | insulin processing(GO:0030070) |
9.1 | 54.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
9.0 | 324.0 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
8.9 | 26.8 | GO:0042126 | nitrate metabolic process(GO:0042126) |
8.9 | 26.6 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
8.8 | 53.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
8.8 | 26.5 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
8.8 | 43.8 | GO:0060327 | cytoplasmic actin-based contraction involved in cell motility(GO:0060327) |
8.8 | 52.6 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
8.7 | 43.5 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
8.6 | 17.2 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
8.6 | 8.6 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
8.5 | 17.0 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
8.5 | 25.5 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
8.5 | 42.5 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
8.4 | 33.7 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
8.4 | 33.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
8.3 | 25.0 | GO:0006552 | leucine catabolic process(GO:0006552) |
8.3 | 16.6 | GO:0007356 | thorax and anterior abdomen determination(GO:0007356) |
8.3 | 16.5 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
8.3 | 16.5 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
8.2 | 33.0 | GO:0000050 | urea cycle(GO:0000050) |
8.2 | 8.2 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
8.2 | 32.8 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
8.2 | 32.6 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
8.1 | 89.6 | GO:0019363 | nicotinamide nucleotide biosynthetic process(GO:0019359) pyridine nucleotide biosynthetic process(GO:0019363) |
8.0 | 24.1 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
8.0 | 15.9 | GO:1904612 | response to 2,3,7,8-tetrachlorodibenzodioxine(GO:1904612) |
7.9 | 39.5 | GO:0006600 | creatine metabolic process(GO:0006600) |
7.9 | 23.6 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
7.8 | 7.8 | GO:0061740 | protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) |
7.8 | 23.4 | GO:1990743 | protein sialylation(GO:1990743) |
7.8 | 15.6 | GO:0035937 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
7.8 | 54.5 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
7.8 | 147.8 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
7.7 | 30.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
7.7 | 23.0 | GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway(GO:0090081) |
7.6 | 30.4 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
7.6 | 30.3 | GO:0035772 | interleukin-13-mediated signaling pathway(GO:0035772) |
7.6 | 37.8 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
7.5 | 60.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
7.5 | 22.6 | GO:0002397 | MHC class I protein complex assembly(GO:0002397) |
7.5 | 15.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
7.4 | 14.9 | GO:0060468 | prevention of polyspermy(GO:0060468) |
7.4 | 22.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
7.4 | 14.9 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
7.4 | 44.5 | GO:0090383 | phagosome acidification(GO:0090383) |
7.3 | 43.9 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
7.3 | 29.1 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
7.2 | 21.7 | GO:1905204 | septum secundum development(GO:0003285) negative regulation of connective tissue replacement(GO:1905204) |
7.2 | 7.2 | GO:1990379 | lipid transport across blood brain barrier(GO:1990379) |
7.1 | 71.3 | GO:0001842 | neural fold formation(GO:0001842) |
7.1 | 7.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
7.1 | 14.2 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
7.1 | 21.2 | GO:0034696 | response to prostaglandin F(GO:0034696) |
7.0 | 34.9 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
6.9 | 20.7 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
6.9 | 48.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
6.9 | 20.6 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
6.8 | 34.2 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
6.8 | 61.4 | GO:0097501 | stress response to metal ion(GO:0097501) |
6.8 | 20.4 | GO:0006106 | fumarate metabolic process(GO:0006106) |
6.8 | 6.8 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
6.7 | 20.2 | GO:0044108 | calcitriol biosynthetic process from calciol(GO:0036378) cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
6.7 | 20.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
6.7 | 46.8 | GO:0043686 | co-translational protein modification(GO:0043686) |
6.7 | 20.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
6.7 | 13.3 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
6.6 | 19.8 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
6.6 | 46.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
6.6 | 19.8 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
6.6 | 19.7 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
6.5 | 19.5 | GO:0035711 | T-helper 1 cell activation(GO:0035711) |
6.5 | 25.9 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
6.5 | 19.4 | GO:0003342 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
6.4 | 45.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
6.4 | 25.7 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
6.3 | 31.6 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
6.3 | 37.8 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
6.3 | 18.8 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
6.3 | 12.5 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
6.2 | 18.7 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
6.2 | 31.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
6.2 | 12.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
6.2 | 111.7 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
6.2 | 55.7 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
6.2 | 18.6 | GO:0009407 | toxin catabolic process(GO:0009407) mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) secondary metabolite catabolic process(GO:0090487) organic heteropentacyclic compound catabolic process(GO:1901377) |
6.2 | 30.8 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
6.1 | 18.3 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
6.1 | 12.2 | GO:0039019 | pronephric nephron development(GO:0039019) |
6.1 | 48.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
6.1 | 36.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
6.0 | 30.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
6.0 | 41.7 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
5.9 | 53.4 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
5.9 | 29.7 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
5.9 | 23.7 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
5.9 | 53.2 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
5.9 | 82.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
5.9 | 11.8 | GO:0048382 | mesendoderm development(GO:0048382) |
5.9 | 17.7 | GO:1904056 | regulation of cholangiocyte proliferation(GO:1904054) positive regulation of cholangiocyte proliferation(GO:1904056) |
5.8 | 17.4 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
5.8 | 40.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
5.7 | 17.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
5.7 | 40.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
5.7 | 5.7 | GO:0033483 | gas homeostasis(GO:0033483) |
5.7 | 28.4 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
5.6 | 117.6 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
5.6 | 11.2 | GO:0015811 | L-cystine transport(GO:0015811) |
5.6 | 11.1 | GO:0048793 | pronephros development(GO:0048793) |
5.5 | 22.2 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
5.5 | 27.6 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
5.5 | 21.9 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
5.5 | 27.3 | GO:0072240 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
5.5 | 283.8 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
5.4 | 10.9 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
5.4 | 16.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
5.4 | 37.7 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
5.3 | 16.0 | GO:0030242 | pexophagy(GO:0030242) |
5.3 | 5.3 | GO:0061017 | hepatoblast differentiation(GO:0061017) |
5.3 | 111.4 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
5.3 | 15.9 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
5.2 | 31.4 | GO:0010044 | response to aluminum ion(GO:0010044) |
5.2 | 10.5 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
5.2 | 15.7 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
5.2 | 20.9 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
5.2 | 36.3 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
5.2 | 25.9 | GO:1904970 | brush border assembly(GO:1904970) |
5.2 | 98.0 | GO:0006101 | citrate metabolic process(GO:0006101) |
5.1 | 20.5 | GO:1904975 | response to bleomycin(GO:1904975) |
5.1 | 5.1 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
5.1 | 45.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
5.1 | 10.2 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
5.1 | 30.4 | GO:0006477 | protein sulfation(GO:0006477) |
5.1 | 45.5 | GO:0002176 | male germ cell proliferation(GO:0002176) |
5.1 | 5.1 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
5.0 | 25.2 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
5.0 | 35.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
5.0 | 5.0 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
5.0 | 40.0 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
5.0 | 20.0 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
5.0 | 29.9 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
5.0 | 14.9 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
5.0 | 14.9 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
5.0 | 39.7 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
4.9 | 14.8 | GO:0032258 | CVT pathway(GO:0032258) |
4.9 | 34.5 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
4.9 | 63.6 | GO:0051013 | microtubule severing(GO:0051013) |
4.9 | 4.9 | GO:0060769 | positive regulation of epithelial cell proliferation involved in prostate gland development(GO:0060769) |
4.8 | 9.7 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
4.8 | 9.7 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
4.8 | 14.4 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
4.8 | 14.4 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
4.8 | 19.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
4.8 | 19.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
4.7 | 19.0 | GO:0061107 | seminal vesicle development(GO:0061107) |
4.7 | 19.0 | GO:0014028 | notochord formation(GO:0014028) |
4.7 | 9.5 | GO:0018963 | phthalate metabolic process(GO:0018963) |
4.7 | 33.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
4.7 | 33.0 | GO:0007144 | female meiosis I(GO:0007144) |
4.7 | 18.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
4.7 | 14.1 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
4.7 | 9.4 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
4.6 | 46.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
4.6 | 4.6 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
4.6 | 36.8 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
4.6 | 50.4 | GO:0006108 | malate metabolic process(GO:0006108) |
4.6 | 32.0 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
4.6 | 22.8 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
4.5 | 22.7 | GO:0048240 | sperm capacitation(GO:0048240) |
4.5 | 9.0 | GO:0032364 | oxygen homeostasis(GO:0032364) |
4.5 | 4.5 | GO:1903094 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
4.5 | 76.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
4.5 | 102.5 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
4.4 | 17.8 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
4.4 | 13.3 | GO:0006710 | androgen catabolic process(GO:0006710) |
4.4 | 17.7 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
4.4 | 4.4 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
4.4 | 17.6 | GO:0061743 | motor learning(GO:0061743) |
4.4 | 17.5 | GO:0050893 | sensory processing(GO:0050893) |
4.4 | 30.6 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
4.4 | 8.8 | GO:0003275 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
4.4 | 30.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
4.4 | 8.7 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
4.4 | 139.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
4.3 | 8.7 | GO:1904057 | negative regulation of sensory perception of pain(GO:1904057) |
4.3 | 30.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
4.3 | 34.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
4.3 | 8.7 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
4.3 | 8.6 | GO:0072179 | kidney rudiment formation(GO:0072003) nephric duct formation(GO:0072179) mesonephric duct formation(GO:0072181) |
4.3 | 8.6 | GO:0009445 | putrescine metabolic process(GO:0009445) |
4.3 | 21.6 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
4.3 | 34.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
4.3 | 8.6 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
4.3 | 4.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
4.3 | 8.6 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
4.3 | 8.5 | GO:0006114 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
4.3 | 12.8 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
4.3 | 12.8 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
4.2 | 4.2 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
4.2 | 4.2 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
4.2 | 25.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
4.2 | 37.8 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
4.2 | 16.7 | GO:0006004 | fucose metabolic process(GO:0006004) |
4.2 | 191.7 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
4.2 | 12.5 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
4.2 | 4.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
4.2 | 16.6 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
4.1 | 12.4 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
4.1 | 20.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
4.1 | 8.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
4.1 | 12.4 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
4.1 | 12.4 | GO:0090249 | cell motility involved in somitogenic axis elongation(GO:0090247) regulation of cell motility involved in somitogenic axis elongation(GO:0090249) |
4.1 | 20.5 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
4.1 | 12.3 | GO:0070084 | protein initiator methionine removal(GO:0070084) |
4.1 | 20.3 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) |
4.0 | 16.1 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
4.0 | 8.0 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
4.0 | 16.0 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
4.0 | 8.0 | GO:1990859 | response to endothelin(GO:1990839) cellular response to endothelin(GO:1990859) |
4.0 | 4.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
4.0 | 15.8 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
3.9 | 19.5 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
3.9 | 3.9 | GO:0071217 | cellular response to external biotic stimulus(GO:0071217) |
3.9 | 7.8 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
3.9 | 7.8 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
3.9 | 58.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
3.9 | 19.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
3.9 | 11.6 | GO:0019230 | proprioception(GO:0019230) |
3.9 | 3.9 | GO:0032264 | IMP salvage(GO:0032264) |
3.8 | 134.5 | GO:0007340 | acrosome reaction(GO:0007340) |
3.8 | 30.5 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
3.8 | 3.8 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
3.8 | 7.5 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
3.8 | 15.0 | GO:0015793 | glycerol transport(GO:0015793) |
3.7 | 22.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
3.7 | 18.7 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
3.7 | 7.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
3.7 | 11.2 | GO:0060816 | random inactivation of X chromosome(GO:0060816) regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
3.7 | 3.7 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
3.7 | 51.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
3.7 | 22.2 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
3.7 | 18.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
3.7 | 66.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
3.7 | 11.0 | GO:0090367 | negative regulation of mRNA modification(GO:0090367) |
3.6 | 3.6 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
3.6 | 7.3 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
3.6 | 47.0 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
3.6 | 7.2 | GO:0072221 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
3.6 | 25.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
3.6 | 17.9 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
3.6 | 10.7 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
3.6 | 10.7 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
3.6 | 17.8 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
3.6 | 3.6 | GO:0099403 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
3.6 | 10.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
3.5 | 21.3 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
3.5 | 3.5 | GO:0035106 | operant conditioning(GO:0035106) |
3.5 | 14.1 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
3.5 | 31.6 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
3.5 | 10.5 | GO:0009301 | snRNA transcription(GO:0009301) |
3.5 | 3.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
3.5 | 14.0 | GO:0030647 | aminoglycoside antibiotic metabolic process(GO:0030647) |
3.5 | 7.0 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
3.5 | 45.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
3.5 | 6.9 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
3.5 | 6.9 | GO:0009826 | unidimensional cell growth(GO:0009826) |
3.5 | 38.0 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
3.5 | 10.4 | GO:0021764 | amygdala development(GO:0021764) |
3.4 | 6.9 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
3.4 | 20.6 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
3.4 | 17.0 | GO:0007343 | egg activation(GO:0007343) |
3.4 | 10.2 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
3.4 | 13.5 | GO:0097068 | response to thyroxine(GO:0097068) |
3.4 | 13.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
3.4 | 6.8 | GO:0061325 | canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) cell proliferation involved in outflow tract morphogenesis(GO:0061325) receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) regulation of cardiac ventricle development(GO:1904412) |
3.4 | 30.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
3.4 | 30.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
3.4 | 13.4 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
3.4 | 26.8 | GO:0043482 | endosome to melanosome transport(GO:0035646) pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
3.3 | 16.7 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
3.3 | 6.6 | GO:1904444 | regulation of establishment of Sertoli cell barrier(GO:1904444) |
3.3 | 13.2 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
3.3 | 3.3 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
3.3 | 9.8 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
3.3 | 29.5 | GO:0007028 | cytoplasm organization(GO:0007028) |
3.3 | 6.6 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
3.3 | 22.8 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
3.3 | 6.5 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
3.3 | 6.5 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
3.2 | 9.7 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
3.2 | 13.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
3.2 | 9.7 | GO:2000682 | positive regulation of rubidium ion transport(GO:2000682) positive regulation of rubidium ion transmembrane transporter activity(GO:2000688) |
3.2 | 32.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
3.2 | 9.7 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
3.2 | 16.1 | GO:0060179 | male mating behavior(GO:0060179) |
3.2 | 9.6 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
3.2 | 38.4 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
3.2 | 12.8 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
3.2 | 12.8 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
3.2 | 9.5 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
3.2 | 12.7 | GO:1901911 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
3.2 | 41.0 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
3.2 | 25.2 | GO:0006068 | ethanol catabolic process(GO:0006068) primary alcohol catabolic process(GO:0034310) |
3.1 | 18.9 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
3.1 | 6.3 | GO:0021603 | cranial nerve formation(GO:0021603) |
3.1 | 12.6 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
3.1 | 9.4 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
3.1 | 116.3 | GO:0007032 | endosome organization(GO:0007032) |
3.1 | 72.3 | GO:0007129 | synapsis(GO:0007129) |
3.1 | 22.0 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
3.1 | 34.5 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
3.1 | 6.3 | GO:0031223 | auditory behavior(GO:0031223) |
3.1 | 18.8 | GO:0072718 | response to cisplatin(GO:0072718) |
3.1 | 34.2 | GO:0001967 | suckling behavior(GO:0001967) |
3.1 | 12.4 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
3.1 | 18.5 | GO:0043587 | tongue morphogenesis(GO:0043587) |
3.1 | 9.2 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
3.1 | 9.2 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
3.1 | 64.6 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
3.1 | 18.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
3.1 | 27.5 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) |
3.1 | 24.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
3.1 | 12.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
3.0 | 21.3 | GO:0060539 | diaphragm development(GO:0060539) |
3.0 | 6.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
3.0 | 9.0 | GO:0071000 | response to magnetism(GO:0071000) |
3.0 | 3.0 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
3.0 | 18.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
3.0 | 12.0 | GO:0032849 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
3.0 | 11.9 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
3.0 | 5.9 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
2.9 | 29.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
2.9 | 8.8 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
2.9 | 8.7 | GO:1903699 | tarsal gland development(GO:1903699) |
2.9 | 5.8 | GO:1904045 | cellular response to aldosterone(GO:1904045) |
2.9 | 26.1 | GO:0033762 | response to glucagon(GO:0033762) |
2.9 | 23.2 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
2.9 | 2.9 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
2.9 | 5.8 | GO:2000437 | regulation of monocyte extravasation(GO:2000437) |
2.9 | 8.6 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
2.9 | 20.0 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
2.9 | 22.9 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
2.8 | 17.0 | GO:0018206 | N-terminal peptidyl-methionine acetylation(GO:0017196) peptidyl-methionine modification(GO:0018206) |
2.8 | 8.5 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
2.8 | 28.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
2.8 | 8.5 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
2.8 | 19.6 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
2.8 | 13.9 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
2.8 | 25.0 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
2.8 | 24.9 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
2.8 | 2.8 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
2.8 | 5.5 | GO:1990478 | response to ultrasound(GO:1990478) |
2.8 | 8.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
2.7 | 27.3 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
2.7 | 30.0 | GO:0003351 | epithelial cilium movement(GO:0003351) |
2.7 | 19.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
2.7 | 10.9 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
2.7 | 29.6 | GO:0045056 | transcytosis(GO:0045056) |
2.7 | 8.0 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
2.7 | 45.4 | GO:0046460 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
2.7 | 2.7 | GO:0072289 | renal vesicle induction(GO:0072034) ureter morphogenesis(GO:0072197) metanephric nephron tubule formation(GO:0072289) |
2.7 | 13.3 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
2.7 | 8.0 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
2.6 | 18.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
2.6 | 5.3 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
2.6 | 28.9 | GO:0000338 | protein deneddylation(GO:0000338) |
2.6 | 21.0 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
2.6 | 15.7 | GO:0050957 | equilibrioception(GO:0050957) |
2.6 | 26.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
2.6 | 5.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
2.6 | 15.6 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
2.6 | 43.7 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
2.6 | 25.7 | GO:0034389 | lipid particle organization(GO:0034389) |
2.6 | 5.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
2.6 | 7.7 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
2.5 | 7.6 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
2.5 | 17.8 | GO:0070633 | transepithelial transport(GO:0070633) |
2.5 | 17.7 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
2.5 | 35.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
2.5 | 15.0 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
2.5 | 19.9 | GO:0032369 | negative regulation of lipid transport(GO:0032369) |
2.5 | 7.5 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
2.5 | 32.3 | GO:0006517 | protein deglycosylation(GO:0006517) |
2.5 | 14.9 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
2.5 | 7.5 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
2.5 | 7.4 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
2.5 | 117.8 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
2.4 | 26.9 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
2.4 | 9.8 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
2.4 | 21.9 | GO:0042574 | retinal metabolic process(GO:0042574) |
2.4 | 21.7 | GO:0046033 | AMP metabolic process(GO:0046033) |
2.4 | 7.2 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
2.4 | 2.4 | GO:0051305 | meiotic chromosome movement towards spindle pole(GO:0016344) chromosome movement towards spindle pole(GO:0051305) |
2.4 | 4.8 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
2.4 | 9.6 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
2.4 | 21.5 | GO:0051450 | myoblast proliferation(GO:0051450) |
2.4 | 7.1 | GO:1901367 | response to L-cysteine(GO:1901367) |
2.4 | 7.1 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
2.3 | 9.3 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
2.3 | 18.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
2.3 | 30.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
2.3 | 13.9 | GO:0006706 | steroid catabolic process(GO:0006706) |
2.3 | 36.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
2.3 | 6.9 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
2.3 | 6.8 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
2.3 | 77.6 | GO:0031018 | endocrine pancreas development(GO:0031018) |
2.3 | 29.5 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
2.3 | 24.9 | GO:0035268 | protein mannosylation(GO:0035268) |
2.3 | 4.5 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
2.2 | 13.5 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
2.2 | 8.9 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
2.2 | 13.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
2.2 | 4.5 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
2.2 | 8.9 | GO:0019563 | glycerol catabolic process(GO:0019563) |
2.2 | 24.4 | GO:0006465 | signal peptide processing(GO:0006465) |
2.2 | 2.2 | GO:0060594 | mammary gland specification(GO:0060594) |
2.2 | 2.2 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
2.2 | 48.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
2.2 | 19.6 | GO:0035608 | protein deglutamylation(GO:0035608) |
2.2 | 4.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
2.2 | 28.2 | GO:0042407 | cristae formation(GO:0042407) |
2.2 | 4.3 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
2.1 | 47.3 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
2.1 | 27.6 | GO:0043248 | proteasome assembly(GO:0043248) |
2.1 | 4.2 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
2.1 | 14.8 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
2.1 | 6.3 | GO:0035036 | sperm-egg recognition(GO:0035036) |
2.1 | 27.4 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
2.1 | 6.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
2.1 | 12.6 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
2.1 | 12.5 | GO:0032025 | response to cobalt ion(GO:0032025) |
2.1 | 6.2 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
2.1 | 47.6 | GO:0045116 | protein neddylation(GO:0045116) |
2.1 | 10.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
2.1 | 4.1 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
2.1 | 6.2 | GO:0071529 | cementum mineralization(GO:0071529) |
2.1 | 55.8 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
2.1 | 8.2 | GO:0006983 | ER overload response(GO:0006983) |
2.1 | 2.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
2.1 | 4.1 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
2.0 | 28.7 | GO:0006783 | heme biosynthetic process(GO:0006783) |
2.0 | 10.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
2.0 | 4.1 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
2.0 | 2.0 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
2.0 | 10.1 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
2.0 | 10.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
2.0 | 14.2 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
2.0 | 10.1 | GO:0015677 | copper ion import(GO:0015677) |
2.0 | 4.0 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
2.0 | 22.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
2.0 | 6.0 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
2.0 | 2.0 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
2.0 | 13.8 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
2.0 | 3.9 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
1.9 | 11.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
1.9 | 13.6 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
1.9 | 13.5 | GO:0070986 | left/right axis specification(GO:0070986) |
1.9 | 5.8 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.9 | 3.8 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) positive regulation of oocyte maturation(GO:1900195) |
1.9 | 1.9 | GO:0032762 | mast cell cytokine production(GO:0032762) |
1.9 | 5.7 | GO:0031989 | bombesin receptor signaling pathway(GO:0031989) |
1.9 | 3.8 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
1.9 | 9.4 | GO:0071569 | protein ufmylation(GO:0071569) |
1.9 | 16.9 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
1.9 | 13.2 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
1.9 | 22.5 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
1.9 | 3.8 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.9 | 48.8 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
1.9 | 15.0 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
1.9 | 3.7 | GO:0032900 | negative regulation of neurotrophin production(GO:0032900) |
1.9 | 11.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
1.9 | 5.6 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
1.8 | 7.4 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
1.8 | 33.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
1.8 | 40.4 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
1.8 | 5.5 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
1.8 | 20.1 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
1.8 | 7.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.8 | 10.9 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
1.8 | 5.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.8 | 10.8 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.8 | 5.4 | GO:0042363 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) fat-soluble vitamin catabolic process(GO:0042363) |
1.8 | 30.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
1.8 | 30.5 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
1.8 | 5.3 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
1.8 | 7.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
1.8 | 8.8 | GO:0071472 | cellular response to salt stress(GO:0071472) |
1.8 | 7.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
1.8 | 5.3 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
1.8 | 26.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
1.8 | 5.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
1.7 | 12.2 | GO:0048840 | otolith development(GO:0048840) |
1.7 | 82.1 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) tRNA aminoacylation(GO:0043039) |
1.7 | 59.3 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
1.7 | 1.7 | GO:0007141 | male meiosis I(GO:0007141) |
1.7 | 109.6 | GO:0030317 | sperm motility(GO:0030317) |
1.7 | 38.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
1.7 | 3.5 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
1.7 | 1.7 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.7 | 6.9 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
1.7 | 20.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
1.7 | 5.1 | GO:0050955 | thermoception(GO:0050955) |
1.7 | 15.4 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
1.7 | 3.4 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
1.7 | 5.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
1.7 | 5.1 | GO:1903225 | integrin biosynthetic process(GO:0045112) negative regulation of endodermal cell differentiation(GO:1903225) |
1.7 | 13.6 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
1.7 | 3.4 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
1.7 | 15.2 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
1.7 | 3.3 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
1.7 | 11.7 | GO:1903543 | positive regulation of exosomal secretion(GO:1903543) |
1.7 | 8.3 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
1.7 | 9.9 | GO:2000035 | regulation of stem cell division(GO:2000035) |
1.7 | 3.3 | GO:0016068 | regulation of type I hypersensitivity(GO:0001810) type I hypersensitivity(GO:0016068) |
1.6 | 11.5 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
1.6 | 18.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.6 | 11.5 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
1.6 | 14.8 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
1.6 | 29.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
1.6 | 4.9 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
1.6 | 4.9 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
1.6 | 4.9 | GO:1990403 | embryonic brain development(GO:1990403) |
1.6 | 4.8 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
1.6 | 1.6 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.6 | 8.0 | GO:0010042 | response to manganese ion(GO:0010042) |
1.6 | 3.2 | GO:0010998 | regulation of translational initiation by eIF2 alpha phosphorylation(GO:0010998) |
1.6 | 8.0 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
1.6 | 12.8 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
1.6 | 23.9 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
1.6 | 4.8 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
1.6 | 8.0 | GO:0033034 | positive regulation of neutrophil apoptotic process(GO:0033031) positive regulation of myeloid cell apoptotic process(GO:0033034) |
1.6 | 4.8 | GO:0032053 | ciliary basal body organization(GO:0032053) positive regulation of protein localization to cilium(GO:1903566) |
1.6 | 3.2 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
1.6 | 1.6 | GO:1902915 | protein poly-ADP-ribosylation(GO:0070212) negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
1.6 | 67.6 | GO:0006414 | translational elongation(GO:0006414) |
1.6 | 3.1 | GO:0036093 | germ cell proliferation(GO:0036093) |
1.6 | 7.8 | GO:0014029 | neural crest formation(GO:0014029) |
1.6 | 34.3 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
1.5 | 1.5 | GO:0044330 | canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) |
1.5 | 4.6 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
1.5 | 53.6 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
1.5 | 1.5 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
1.5 | 91.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
1.5 | 3.0 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
1.5 | 7.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
1.5 | 9.0 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
1.5 | 10.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
1.5 | 4.5 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
1.5 | 4.4 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
1.5 | 13.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.5 | 4.4 | GO:0009597 | detection of virus(GO:0009597) |
1.5 | 7.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
1.5 | 11.7 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
1.5 | 2.9 | GO:0061009 | common bile duct development(GO:0061009) |
1.5 | 5.8 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
1.5 | 5.8 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
1.4 | 52.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
1.4 | 7.2 | GO:0035627 | ceramide transport(GO:0035627) |
1.4 | 15.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
1.4 | 4.3 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
1.4 | 10.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
1.4 | 2.9 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
1.4 | 7.1 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.4 | 8.5 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
1.4 | 2.8 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
1.4 | 1.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
1.4 | 8.4 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
1.4 | 5.6 | GO:0006544 | glycine metabolic process(GO:0006544) |
1.4 | 4.2 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
1.4 | 2.8 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
1.4 | 7.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.4 | 4.2 | GO:1904178 | sterol regulatory element binding protein import into nucleus(GO:0035105) negative regulation of adipose tissue development(GO:1904178) |
1.4 | 37.7 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
1.4 | 5.6 | GO:0046040 | IMP metabolic process(GO:0046040) |
1.4 | 7.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
1.4 | 5.6 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
1.4 | 6.9 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
1.4 | 12.5 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
1.4 | 11.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
1.4 | 4.1 | GO:1902963 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
1.4 | 13.8 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.4 | 6.9 | GO:0030432 | peristalsis(GO:0030432) |
1.4 | 4.1 | GO:2000293 | regulation of defecation(GO:2000292) negative regulation of defecation(GO:2000293) |
1.4 | 6.9 | GO:0015684 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
1.4 | 4.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
1.4 | 8.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
1.3 | 8.0 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
1.3 | 1.3 | GO:0071387 | cellular response to cortisol stimulus(GO:0071387) |
1.3 | 30.5 | GO:0006986 | response to unfolded protein(GO:0006986) |
1.3 | 35.2 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
1.3 | 5.2 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
1.3 | 5.2 | GO:0015889 | cobalamin transport(GO:0015889) |
1.3 | 5.2 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
1.3 | 2.6 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
1.3 | 3.9 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
1.3 | 20.4 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
1.3 | 3.8 | GO:0008209 | androgen metabolic process(GO:0008209) |
1.3 | 10.2 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
1.3 | 3.8 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.3 | 6.3 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
1.3 | 7.5 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
1.3 | 15.1 | GO:1904030 | negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
1.3 | 3.8 | GO:0022900 | electron transport chain(GO:0022900) |
1.3 | 1.3 | GO:0060702 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
1.3 | 3.8 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
1.2 | 6.2 | GO:0043586 | tongue development(GO:0043586) |
1.2 | 6.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
1.2 | 4.9 | GO:0030576 | Cajal body organization(GO:0030576) |
1.2 | 2.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.2 | 7.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
1.2 | 2.4 | GO:0071362 | cellular response to ether(GO:0071362) response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
1.2 | 4.9 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.2 | 3.6 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
1.2 | 8.5 | GO:1901374 | acetate ester transport(GO:1901374) |
1.2 | 20.6 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
1.2 | 4.8 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
1.2 | 4.8 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
1.2 | 4.8 | GO:0001555 | oocyte growth(GO:0001555) |
1.2 | 4.8 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
1.2 | 7.2 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
1.2 | 16.8 | GO:0016180 | snRNA processing(GO:0016180) |
1.2 | 2.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.2 | 21.6 | GO:0044458 | motile cilium assembly(GO:0044458) |
1.2 | 7.2 | GO:0048102 | autophagic cell death(GO:0048102) |
1.2 | 8.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
1.2 | 7.1 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
1.2 | 19.9 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
1.2 | 11.7 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
1.2 | 16.3 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
1.2 | 2.3 | GO:0016078 | tRNA catabolic process(GO:0016078) |
1.1 | 42.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
1.1 | 5.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
1.1 | 10.1 | GO:0048665 | neuron fate specification(GO:0048665) |
1.1 | 5.6 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
1.1 | 34.4 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
1.1 | 5.5 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
1.1 | 2.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.1 | 9.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.1 | 14.3 | GO:0098880 | maintenance of postsynaptic specialization structure(GO:0098880) maintenance of postsynaptic density structure(GO:0099562) |
1.1 | 1.1 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
1.1 | 4.4 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.1 | 2.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.1 | 7.6 | GO:0046051 | UTP metabolic process(GO:0046051) |
1.1 | 10.8 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
1.1 | 2.2 | GO:0046104 | thymidine metabolic process(GO:0046104) |
1.1 | 1.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
1.1 | 2.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.1 | 39.2 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
1.1 | 6.3 | GO:0070669 | response to interleukin-2(GO:0070669) |
1.0 | 16.8 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
1.0 | 8.4 | GO:0016125 | sterol metabolic process(GO:0016125) |
1.0 | 5.2 | GO:0060157 | urinary bladder development(GO:0060157) |
1.0 | 18.7 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
1.0 | 3.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
1.0 | 4.0 | GO:0009115 | xanthine catabolic process(GO:0009115) |
1.0 | 9.0 | GO:0042572 | retinol metabolic process(GO:0042572) |
1.0 | 320.6 | GO:0007283 | spermatogenesis(GO:0007283) |
1.0 | 4.0 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
1.0 | 2.0 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
1.0 | 1.9 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.9 | 12.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.9 | 3.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.9 | 26.3 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.9 | 9.3 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.9 | 14.7 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.9 | 7.3 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.9 | 4.6 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.9 | 1.8 | GO:0072658 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) |
0.9 | 1.8 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.9 | 1.8 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.9 | 10.8 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.9 | 1.8 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.9 | 2.7 | GO:0048664 | neuron fate determination(GO:0048664) |
0.9 | 5.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.9 | 10.7 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.9 | 0.9 | GO:0090009 | primitive streak formation(GO:0090009) |
0.9 | 18.3 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.9 | 5.2 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.9 | 35.4 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.9 | 2.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.9 | 3.4 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.9 | 3.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.8 | 8.5 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.8 | 18.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.8 | 3.4 | GO:0061709 | reticulophagy(GO:0061709) |
0.8 | 2.5 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.8 | 9.2 | GO:0006312 | mitotic recombination(GO:0006312) |
0.8 | 3.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.8 | 10.7 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.8 | 7.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.8 | 6.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.8 | 9.0 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.8 | 0.8 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.8 | 4.0 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.8 | 3.2 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.8 | 4.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.8 | 12.7 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.8 | 2.4 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.8 | 7.8 | GO:0019532 | oxalate transport(GO:0019532) |
0.8 | 23.4 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.8 | 10.1 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.8 | 1.6 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.8 | 4.7 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.8 | 2.3 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.8 | 8.5 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.8 | 0.8 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.8 | 9.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.8 | 7.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.8 | 5.3 | GO:0015747 | urate transport(GO:0015747) |
0.7 | 0.7 | GO:0051867 | general adaptation syndrome, behavioral process(GO:0051867) |
0.7 | 2.2 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.7 | 5.2 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.7 | 1.5 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.7 | 5.2 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.7 | 2.2 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
0.7 | 5.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.7 | 11.4 | GO:0001964 | startle response(GO:0001964) |
0.7 | 7.6 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.7 | 6.9 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.7 | 2.7 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.7 | 5.4 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.7 | 12.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.7 | 2.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.7 | 1.3 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
0.7 | 3.4 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.7 | 2.7 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.7 | 5.3 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.7 | 11.2 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.7 | 2.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.7 | 0.7 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.7 | 4.0 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.7 | 2.0 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.7 | 0.7 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.6 | 3.9 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.6 | 4.5 | GO:0046415 | urate metabolic process(GO:0046415) |
0.6 | 1.9 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) |
0.6 | 1.3 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.6 | 0.6 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.6 | 1.9 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.6 | 1.9 | GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
0.6 | 18.0 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.6 | 0.6 | GO:0019086 | late viral transcription(GO:0019086) |
0.6 | 22.2 | GO:0051298 | centrosome duplication(GO:0051298) |
0.6 | 10.5 | GO:0043648 | dicarboxylic acid metabolic process(GO:0043648) |
0.6 | 0.6 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.6 | 3.7 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.6 | 0.6 | GO:0070471 | uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) |
0.6 | 1.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.6 | 2.4 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.6 | 1.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.6 | 5.8 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.6 | 1.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.6 | 1.7 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.6 | 7.9 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.6 | 1.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.6 | 9.0 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.6 | 11.7 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.6 | 14.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.6 | 2.2 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.5 | 18.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.5 | 5.4 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.5 | 1.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.5 | 5.9 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.5 | 2.2 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.5 | 1.1 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.5 | 2.7 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.5 | 1.6 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.5 | 0.5 | GO:0009644 | response to high light intensity(GO:0009644) |
0.5 | 8.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.5 | 5.8 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.5 | 13.1 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.5 | 2.1 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.5 | 1.0 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.5 | 3.1 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
0.5 | 1.5 | GO:0014739 | positive regulation of muscle hyperplasia(GO:0014739) |
0.5 | 9.7 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.5 | 2.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.5 | 3.0 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.5 | 3.0 | GO:0070166 | enamel mineralization(GO:0070166) |
0.5 | 1.5 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.5 | 8.0 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.5 | 4.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.5 | 6.8 | GO:0060074 | synapse maturation(GO:0060074) |
0.5 | 9.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.5 | 5.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.5 | 2.9 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.5 | 5.3 | GO:0042737 | drug catabolic process(GO:0042737) |
0.5 | 1.4 | GO:0035878 | nail development(GO:0035878) |
0.5 | 5.6 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.5 | 2.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.5 | 1.8 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.5 | 1.4 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.5 | 7.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.4 | 3.6 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.4 | 1.3 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.4 | 1.8 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.4 | 4.9 | GO:0003341 | cilium movement(GO:0003341) |
0.4 | 5.7 | GO:0060416 | response to growth hormone(GO:0060416) |
0.4 | 7.0 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.4 | 0.9 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.4 | 3.5 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.4 | 3.0 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.4 | 0.9 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.4 | 1.7 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.4 | 2.5 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.4 | 0.8 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.4 | 2.1 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.4 | 2.0 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.4 | 1.2 | GO:0009750 | response to fructose(GO:0009750) |
0.4 | 1.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.4 | 6.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.4 | 5.3 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.4 | 1.6 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.4 | 2.0 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.4 | 0.8 | GO:0060253 | negative regulation of glial cell proliferation(GO:0060253) |
0.4 | 0.8 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.4 | 2.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.4 | 1.1 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.4 | 0.4 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.4 | 1.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.4 | 22.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.4 | 1.1 | GO:1901073 | N-acetylglucosamine biosynthetic process(GO:0006045) N-acetylneuraminate biosynthetic process(GO:0046380) glucosamine-containing compound biosynthetic process(GO:1901073) |
0.4 | 1.8 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.4 | 0.4 | GO:0072202 | cell differentiation involved in metanephros development(GO:0072202) |
0.4 | 9.4 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.3 | 1.4 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.3 | 0.3 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.3 | 0.7 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.3 | 2.0 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.3 | 0.7 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.3 | 3.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.3 | 3.9 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.3 | 3.8 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
0.3 | 0.6 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.3 | 0.3 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
0.3 | 1.2 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.3 | 6.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.3 | 29.2 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.3 | 6.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.3 | 3.8 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.3 | 6.2 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.3 | 1.2 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.3 | 2.0 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.3 | 2.0 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.3 | 1.7 | GO:0002192 | cap-independent translational initiation(GO:0002190) IRES-dependent translational initiation(GO:0002192) |
0.3 | 0.8 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.3 | 0.8 | GO:0016240 | autophagosome docking(GO:0016240) |
0.3 | 0.8 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
0.3 | 1.4 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.3 | 1.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.3 | 1.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.3 | 1.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.3 | 1.8 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 3.8 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.3 | 1.3 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.3 | 2.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 1.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 10.0 | GO:0006400 | tRNA modification(GO:0006400) |
0.2 | 13.0 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.2 | 1.3 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.2 | 0.4 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.2 | 1.7 | GO:0032400 | melanosome localization(GO:0032400) |
0.2 | 2.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 7.0 | GO:0060173 | appendage development(GO:0048736) limb development(GO:0060173) |
0.2 | 2.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 0.6 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.2 | 0.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 0.4 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.2 | 0.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.2 | 0.8 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.2 | 0.8 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.2 | 0.7 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 0.7 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 0.1 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
0.1 | 0.9 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 1.0 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 2.5 | GO:0098781 | rRNA transcription(GO:0009303) ncRNA transcription(GO:0098781) |
0.1 | 164.2 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.5 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 7.3 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 0.6 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.1 | 0.2 | GO:0036514 | dopaminergic neuron axon guidance(GO:0036514) serotonergic neuron axon guidance(GO:0036515) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.1 | 0.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 2.6 | GO:0006112 | energy reserve metabolic process(GO:0006112) |
0.1 | 0.3 | GO:0097502 | mannosylation(GO:0097502) |
0.1 | 2.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.4 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.1 | 0.6 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.2 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.1 | 4.1 | GO:0045333 | cellular respiration(GO:0045333) |
0.1 | 0.8 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.1 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.1 | 0.5 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.1 | GO:0034776 | response to histamine(GO:0034776) |
0.1 | 1.9 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.1 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.5 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 0.1 | GO:0051030 | snRNA transport(GO:0051030) |
0.0 | 0.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.3 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.2 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.0 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.0 | 0.0 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.1 | GO:0072575 | hepatocyte proliferation(GO:0072574) epithelial cell proliferation involved in liver morphogenesis(GO:0072575) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
43.3 | 130.0 | GO:0044317 | rod spherule(GO:0044317) |
24.4 | 146.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
22.7 | 68.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
21.7 | 65.1 | GO:0000802 | transverse filament(GO:0000802) |
20.9 | 125.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
19.9 | 317.7 | GO:0070852 | cell body fiber(GO:0070852) |
18.2 | 54.6 | GO:0005960 | glycine cleavage complex(GO:0005960) |
18.2 | 236.1 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
17.8 | 89.2 | GO:0070695 | FHF complex(GO:0070695) |
17.5 | 87.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
15.4 | 46.3 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
14.3 | 42.9 | GO:0044316 | cone cell pedicle(GO:0044316) |
13.0 | 13.0 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
12.7 | 38.2 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
10.8 | 118.8 | GO:0005915 | zonula adherens(GO:0005915) |
10.5 | 31.6 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
9.9 | 158.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
9.8 | 39.3 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
9.5 | 28.6 | GO:0071942 | XPC complex(GO:0071942) |
9.3 | 27.8 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
9.2 | 27.6 | GO:0055087 | Ski complex(GO:0055087) |
9.1 | 36.4 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
9.1 | 36.4 | GO:0035363 | histone locus body(GO:0035363) |
8.9 | 187.9 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
8.7 | 52.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
8.6 | 42.8 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
8.5 | 42.5 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
8.4 | 50.6 | GO:0097422 | tubular endosome(GO:0097422) |
8.4 | 33.6 | GO:1990005 | granular vesicle(GO:1990005) |
8.4 | 25.1 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
8.3 | 24.9 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) fumarate reductase complex(GO:0045283) |
8.2 | 8.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
8.1 | 56.6 | GO:0070449 | elongin complex(GO:0070449) |
8.0 | 40.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
7.6 | 83.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
7.6 | 22.7 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
7.5 | 37.7 | GO:0048179 | activin receptor complex(GO:0048179) |
7.5 | 22.4 | GO:1990429 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
7.3 | 43.7 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
7.2 | 21.7 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
7.2 | 21.5 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
7.0 | 147.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
6.6 | 73.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
6.5 | 25.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
6.4 | 38.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
6.2 | 43.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
6.1 | 6.1 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
5.9 | 23.6 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
5.9 | 17.7 | GO:0008537 | proteasome activator complex(GO:0008537) |
5.8 | 23.1 | GO:0031417 | NatC complex(GO:0031417) |
5.7 | 17.0 | GO:1990357 | terminal web(GO:1990357) |
5.7 | 22.7 | GO:0072487 | MSL complex(GO:0072487) |
5.6 | 22.6 | GO:0032280 | symmetric synapse(GO:0032280) |
5.6 | 22.4 | GO:0061474 | phagolysosome membrane(GO:0061474) |
5.6 | 16.8 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
5.6 | 66.7 | GO:0000801 | central element(GO:0000801) |
5.6 | 72.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
5.5 | 110.5 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
5.4 | 118.8 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
5.2 | 31.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
5.2 | 5.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
5.2 | 20.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
5.2 | 135.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
5.2 | 15.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
5.1 | 36.0 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
5.1 | 36.0 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
5.1 | 5.1 | GO:0045273 | respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) |
5.1 | 86.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
5.0 | 5.0 | GO:0060187 | cell pole(GO:0060187) |
4.9 | 53.8 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
4.8 | 24.0 | GO:0030891 | VCB complex(GO:0030891) |
4.7 | 85.0 | GO:0032433 | filopodium tip(GO:0032433) |
4.7 | 42.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
4.7 | 14.0 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
4.7 | 42.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
4.7 | 28.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
4.6 | 32.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
4.5 | 49.7 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
4.5 | 35.9 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
4.3 | 13.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
4.2 | 101.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
4.2 | 611.2 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
4.2 | 37.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
4.0 | 35.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
3.9 | 19.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
3.8 | 26.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
3.8 | 26.8 | GO:0071203 | WASH complex(GO:0071203) |
3.7 | 48.7 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
3.7 | 33.7 | GO:0045179 | apical cortex(GO:0045179) |
3.7 | 55.9 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
3.7 | 14.9 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
3.7 | 7.4 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
3.7 | 44.0 | GO:0032426 | stereocilium tip(GO:0032426) |
3.7 | 29.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
3.6 | 36.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
3.6 | 93.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
3.6 | 21.5 | GO:0005787 | signal peptidase complex(GO:0005787) |
3.5 | 1061.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
3.5 | 10.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
3.5 | 21.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
3.5 | 21.2 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
3.5 | 31.4 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
3.4 | 224.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
3.4 | 13.6 | GO:0044301 | climbing fiber(GO:0044301) |
3.3 | 16.7 | GO:0097452 | GAIT complex(GO:0097452) |
3.3 | 56.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
3.3 | 13.3 | GO:0030478 | actin cap(GO:0030478) |
3.3 | 36.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
3.2 | 9.7 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
3.2 | 22.4 | GO:0061617 | MICOS complex(GO:0061617) |
3.2 | 419.8 | GO:0001669 | acrosomal vesicle(GO:0001669) |
3.2 | 15.9 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
3.2 | 47.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
3.1 | 9.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
3.0 | 21.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
3.0 | 12.0 | GO:0090543 | Flemming body(GO:0090543) |
3.0 | 11.8 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
3.0 | 11.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
2.8 | 58.2 | GO:0005922 | connexon complex(GO:0005922) |
2.8 | 2.8 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
2.8 | 19.4 | GO:0001739 | sex chromatin(GO:0001739) |
2.7 | 8.2 | GO:0098830 | presynaptic endosome(GO:0098830) |
2.7 | 8.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
2.7 | 10.7 | GO:0070876 | SOSS complex(GO:0070876) |
2.7 | 8.0 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
2.5 | 15.2 | GO:0070847 | core mediator complex(GO:0070847) |
2.5 | 7.6 | GO:0005745 | m-AAA complex(GO:0005745) |
2.5 | 10.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
2.5 | 15.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
2.5 | 12.3 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
2.4 | 2.4 | GO:0098835 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
2.4 | 9.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
2.4 | 127.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
2.4 | 21.6 | GO:0070652 | HAUS complex(GO:0070652) |
2.3 | 72.6 | GO:0035861 | site of double-strand break(GO:0035861) |
2.3 | 16.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
2.3 | 9.2 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
2.3 | 13.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
2.2 | 9.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
2.2 | 11.0 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
2.2 | 99.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
2.2 | 43.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
2.1 | 12.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
2.1 | 4.3 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
2.1 | 10.5 | GO:0097413 | Lewy body(GO:0097413) |
2.1 | 14.5 | GO:0005827 | polar microtubule(GO:0005827) |
2.0 | 6.1 | GO:0061574 | ASAP complex(GO:0061574) |
2.0 | 48.0 | GO:0000795 | synaptonemal complex(GO:0000795) |
2.0 | 13.9 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
1.9 | 22.7 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
1.9 | 7.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.9 | 11.2 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.9 | 18.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
1.8 | 12.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.8 | 7.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
1.8 | 14.5 | GO:0031209 | SCAR complex(GO:0031209) |
1.8 | 35.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
1.7 | 7.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
1.7 | 19.2 | GO:0030008 | TRAPP complex(GO:0030008) |
1.7 | 3.5 | GO:1990462 | omegasome membrane(GO:1903349) omegasome(GO:1990462) |
1.7 | 5.2 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
1.7 | 3.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.7 | 12.0 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
1.7 | 60.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
1.7 | 20.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
1.7 | 11.9 | GO:0031415 | NatA complex(GO:0031415) |
1.7 | 13.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
1.7 | 5.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
1.7 | 166.4 | GO:0072562 | blood microparticle(GO:0072562) |
1.7 | 11.7 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
1.7 | 11.6 | GO:0016342 | catenin complex(GO:0016342) |
1.7 | 1.7 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
1.6 | 59.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
1.6 | 36.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
1.6 | 47.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
1.6 | 8.1 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
1.6 | 11.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
1.6 | 8.0 | GO:0044194 | cytolytic granule(GO:0044194) |
1.6 | 19.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
1.6 | 3.2 | GO:0034774 | secretory granule lumen(GO:0034774) |
1.6 | 11.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.6 | 106.2 | GO:0031526 | brush border membrane(GO:0031526) |
1.5 | 59.8 | GO:0005844 | polysome(GO:0005844) |
1.5 | 15.3 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
1.5 | 19.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
1.5 | 16.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.5 | 8.9 | GO:0005796 | Golgi lumen(GO:0005796) |
1.5 | 13.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.4 | 5.7 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
1.4 | 8.6 | GO:0033391 | chromatoid body(GO:0033391) |
1.4 | 2067.1 | GO:0005739 | mitochondrion(GO:0005739) |
1.4 | 7.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.4 | 45.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
1.4 | 38.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
1.4 | 19.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.4 | 61.8 | GO:0005637 | nuclear inner membrane(GO:0005637) |
1.3 | 699.8 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
1.3 | 28.2 | GO:0032420 | stereocilium(GO:0032420) |
1.3 | 4.0 | GO:0043511 | inhibin complex(GO:0043511) |
1.3 | 14.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
1.3 | 2.5 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
1.3 | 31.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.3 | 16.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.2 | 24.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
1.2 | 12.1 | GO:0072687 | meiotic spindle(GO:0072687) |
1.2 | 25.2 | GO:0045120 | pronucleus(GO:0045120) |
1.2 | 13.1 | GO:0030057 | desmosome(GO:0030057) |
1.2 | 20.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.2 | 11.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.1 | 7.8 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
1.1 | 8.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.1 | 4.4 | GO:0005606 | laminin-1 complex(GO:0005606) |
1.0 | 5.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.0 | 40.1 | GO:0043034 | costamere(GO:0043034) |
1.0 | 62.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
1.0 | 1.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.0 | 59.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
1.0 | 4.0 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
1.0 | 10.8 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
1.0 | 47.6 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
1.0 | 37.1 | GO:0005811 | lipid particle(GO:0005811) |
0.9 | 3.8 | GO:1990393 | 3M complex(GO:1990393) |
0.9 | 8.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.9 | 2.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.9 | 13.0 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.9 | 2.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.9 | 8.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.9 | 8.0 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.9 | 4.4 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.9 | 1.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.9 | 1.7 | GO:0034455 | t-UTP complex(GO:0034455) |
0.9 | 12.9 | GO:0032039 | integrator complex(GO:0032039) |
0.8 | 40.4 | GO:0005776 | autophagosome(GO:0005776) |
0.8 | 4.8 | GO:0099571 | postsynaptic actin cytoskeleton(GO:0098871) postsynaptic cytoskeleton(GO:0099571) |
0.8 | 4.8 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.8 | 2.3 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.7 | 8.1 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.7 | 1.5 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.7 | 3.3 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.7 | 6.6 | GO:0035102 | PRC1 complex(GO:0035102) |
0.7 | 0.7 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.7 | 2.6 | GO:0032021 | NELF complex(GO:0032021) |
0.6 | 1.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.6 | 1.8 | GO:1990879 | CST complex(GO:1990879) |
0.6 | 6.8 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.6 | 5.5 | GO:0005839 | proteasome core complex(GO:0005839) |
0.6 | 24.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.5 | 1.1 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.5 | 2.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.5 | 2.1 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.5 | 3.1 | GO:0036396 | MIS complex(GO:0036396) |
0.5 | 1.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.5 | 6.1 | GO:0005861 | troponin complex(GO:0005861) |
0.5 | 1.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.5 | 0.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.5 | 2.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.5 | 3.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.5 | 4.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
0.5 | 30.5 | GO:0045095 | keratin filament(GO:0045095) |
0.4 | 2.5 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.4 | 3.2 | GO:0002177 | manchette(GO:0002177) |
0.3 | 1.4 | GO:0018444 | translation release factor complex(GO:0018444) |
0.3 | 5.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.3 | 0.7 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.3 | 10.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 4.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 1.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.3 | 1.8 | GO:0000125 | PCAF complex(GO:0000125) |
0.3 | 3.5 | GO:0032797 | SMN complex(GO:0032797) |
0.3 | 1.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 1.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 0.8 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.3 | 2.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.3 | 1.9 | GO:0033263 | CORVET complex(GO:0033263) |
0.3 | 2.3 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.2 | 2.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 0.5 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 2.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 8.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 0.6 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.2 | 2.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 1.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 1.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.5 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.2 | 2.1 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 2.0 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.6 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.1 | 0.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.9 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.1 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.0 | 1.2 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.8 | GO:0044291 | cell-cell contact zone(GO:0044291) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
47.1 | 188.5 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
44.8 | 134.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
44.6 | 223.2 | GO:0004103 | choline kinase activity(GO:0004103) |
38.1 | 114.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
32.0 | 95.9 | GO:0008405 | arachidonic acid 11,12-epoxygenase activity(GO:0008405) |
28.5 | 113.8 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
28.4 | 85.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
28.2 | 84.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
28.1 | 84.3 | GO:0004359 | glutaminase activity(GO:0004359) |
27.1 | 135.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
26.1 | 78.2 | GO:0004736 | pyruvate carboxylase activity(GO:0004736) |
25.7 | 77.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
25.1 | 75.3 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
25.1 | 100.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
25.0 | 75.0 | GO:0008142 | oxysterol binding(GO:0008142) |
24.7 | 74.2 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
23.1 | 46.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
22.7 | 68.0 | GO:0046911 | metal chelating activity(GO:0046911) |
21.4 | 85.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
21.2 | 169.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
20.2 | 40.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) |
19.8 | 59.4 | GO:0004655 | porphobilinogen synthase activity(GO:0004655) |
19.7 | 59.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
19.3 | 77.3 | GO:0051870 | methotrexate binding(GO:0051870) |
18.8 | 37.5 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
18.7 | 56.0 | GO:0047635 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
18.1 | 54.2 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
17.5 | 70.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
17.1 | 51.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
16.6 | 49.9 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
16.5 | 49.6 | GO:0032810 | sterol response element binding(GO:0032810) |
16.2 | 48.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
16.1 | 113.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
16.0 | 48.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
15.8 | 15.8 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
15.6 | 46.8 | GO:0015203 | polyamine transmembrane transporter activity(GO:0015203) putrescine transmembrane transporter activity(GO:0015489) |
15.5 | 31.0 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
15.2 | 75.8 | GO:0070404 | NADH binding(GO:0070404) |
15.1 | 226.6 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
14.7 | 44.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
14.6 | 43.9 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
14.5 | 43.5 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
14.5 | 58.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
14.3 | 43.0 | GO:2001070 | starch binding(GO:2001070) |
14.3 | 14.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
13.9 | 41.6 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
13.4 | 120.4 | GO:0008494 | translation activator activity(GO:0008494) |
13.1 | 52.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
13.0 | 91.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
12.5 | 49.9 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
12.4 | 49.4 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
12.1 | 36.4 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) |
11.8 | 106.3 | GO:0070402 | NADPH binding(GO:0070402) |
11.8 | 59.0 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
11.6 | 92.7 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
11.6 | 34.7 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
11.5 | 57.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
11.4 | 297.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
11.2 | 56.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
11.0 | 99.0 | GO:0019841 | retinol binding(GO:0019841) |
11.0 | 241.9 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
10.9 | 427.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
10.9 | 32.8 | GO:0004046 | aminoacylase activity(GO:0004046) |
10.7 | 53.6 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
10.7 | 42.8 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
10.7 | 63.9 | GO:0005499 | vitamin D binding(GO:0005499) |
10.6 | 42.6 | GO:0033149 | FFAT motif binding(GO:0033149) |
10.6 | 31.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
10.6 | 31.7 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
10.5 | 115.7 | GO:0039706 | co-receptor binding(GO:0039706) |
10.5 | 31.5 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
10.5 | 41.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
10.3 | 31.0 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
10.1 | 80.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
10.0 | 90.1 | GO:0005542 | folic acid binding(GO:0005542) |
9.9 | 29.7 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
9.9 | 29.6 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
9.7 | 38.9 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
9.7 | 19.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
9.4 | 28.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
9.4 | 37.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
9.3 | 18.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
9.2 | 27.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
9.0 | 35.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
9.0 | 98.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
8.9 | 8.9 | GO:0016151 | nickel cation binding(GO:0016151) |
8.7 | 26.2 | GO:0043295 | glutathione binding(GO:0043295) |
8.7 | 61.0 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
8.5 | 8.5 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
8.4 | 25.3 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
8.4 | 42.2 | GO:0035473 | lipase binding(GO:0035473) |
8.3 | 8.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
8.3 | 24.9 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
8.3 | 49.8 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
8.2 | 41.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
8.2 | 24.5 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
8.0 | 40.2 | GO:0001155 | TFIIIA-class transcription factor binding(GO:0001155) |
8.0 | 64.2 | GO:0015232 | heme transporter activity(GO:0015232) |
7.8 | 39.2 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
7.8 | 31.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
7.8 | 31.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
7.8 | 31.0 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
7.6 | 22.9 | GO:0038100 | nodal binding(GO:0038100) |
7.5 | 29.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
7.5 | 22.4 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
7.4 | 22.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
7.4 | 22.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
7.4 | 29.6 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
7.4 | 22.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
7.4 | 58.8 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
7.3 | 29.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
7.2 | 72.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
7.2 | 21.5 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
7.2 | 28.6 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
7.0 | 28.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
7.0 | 21.0 | GO:0004335 | galactokinase activity(GO:0004335) |
7.0 | 34.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
7.0 | 34.9 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
6.9 | 62.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
6.9 | 27.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
6.8 | 27.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
6.6 | 32.9 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
6.6 | 65.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
6.5 | 58.3 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
6.5 | 116.5 | GO:0015643 | toxic substance binding(GO:0015643) |
6.4 | 19.2 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
6.4 | 31.9 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
6.3 | 139.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
6.2 | 6.2 | GO:0038132 | neuregulin binding(GO:0038132) |
6.0 | 36.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
6.0 | 59.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
5.9 | 83.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
5.9 | 77.0 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
5.9 | 23.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
5.9 | 17.6 | GO:0004040 | amidase activity(GO:0004040) |
5.8 | 40.8 | GO:0034711 | inhibin binding(GO:0034711) |
5.8 | 23.3 | GO:0047619 | acylcarnitine hydrolase activity(GO:0047619) |
5.8 | 69.7 | GO:0016208 | AMP binding(GO:0016208) |
5.7 | 11.4 | GO:0097677 | STAT family protein binding(GO:0097677) |
5.7 | 22.9 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
5.7 | 11.4 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
5.7 | 74.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
5.7 | 28.3 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
5.6 | 5.6 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
5.5 | 49.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
5.5 | 11.1 | GO:0098603 | selenol Se-methyltransferase activity(GO:0098603) |
5.5 | 215.3 | GO:0070330 | aromatase activity(GO:0070330) |
5.5 | 16.5 | GO:0070012 | oligopeptidase activity(GO:0070012) |
5.5 | 10.9 | GO:0070698 | type I activin receptor binding(GO:0070698) |
5.5 | 27.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
5.3 | 21.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
5.3 | 42.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
5.3 | 21.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
5.3 | 15.9 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
5.3 | 26.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
5.2 | 15.7 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
5.2 | 36.3 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
5.2 | 56.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
5.1 | 15.4 | GO:0036470 | tyrosine 3-monooxygenase activator activity(GO:0036470) L-dopa decarboxylase activator activity(GO:0036478) |
5.1 | 51.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
5.1 | 35.9 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
5.1 | 5.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
5.0 | 30.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
5.0 | 19.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
5.0 | 14.9 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
4.8 | 38.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
4.8 | 14.5 | GO:0008396 | oxysterol 7-alpha-hydroxylase activity(GO:0008396) |
4.8 | 24.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
4.8 | 81.9 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
4.8 | 28.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
4.8 | 28.7 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
4.7 | 14.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
4.7 | 14.2 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
4.7 | 14.2 | GO:0070905 | serine binding(GO:0070905) |
4.6 | 13.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
4.6 | 9.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
4.6 | 13.7 | GO:0034618 | arginine binding(GO:0034618) |
4.6 | 22.8 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
4.5 | 94.4 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
4.5 | 22.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
4.5 | 13.4 | GO:0004925 | prolactin receptor activity(GO:0004925) |
4.4 | 4.4 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
4.4 | 52.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
4.3 | 34.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
4.3 | 43.3 | GO:0070888 | E-box binding(GO:0070888) |
4.3 | 8.6 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
4.3 | 77.7 | GO:0005537 | mannose binding(GO:0005537) |
4.3 | 17.3 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
4.3 | 12.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
4.3 | 17.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
4.3 | 25.7 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
4.3 | 17.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
4.2 | 42.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
4.2 | 33.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
4.2 | 25.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
4.2 | 4.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
4.2 | 46.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
4.2 | 25.0 | GO:0001159 | core promoter proximal region DNA binding(GO:0001159) |
4.1 | 33.0 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
4.1 | 78.0 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
4.1 | 69.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
4.1 | 32.6 | GO:0016405 | CoA-ligase activity(GO:0016405) |
4.1 | 40.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
4.1 | 89.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
4.0 | 52.6 | GO:0070628 | proteasome binding(GO:0070628) |
4.0 | 12.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
4.0 | 24.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
4.0 | 72.4 | GO:0010181 | FMN binding(GO:0010181) |
4.0 | 28.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
4.0 | 20.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
3.9 | 19.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
3.9 | 11.8 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
3.9 | 19.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
3.9 | 23.4 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
3.9 | 19.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
3.9 | 54.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
3.9 | 31.0 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
3.9 | 42.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
3.8 | 106.3 | GO:0008198 | ferrous iron binding(GO:0008198) |
3.8 | 11.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
3.7 | 33.7 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
3.7 | 3.7 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
3.7 | 48.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
3.7 | 14.8 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
3.7 | 22.0 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
3.7 | 11.0 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
3.6 | 43.5 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
3.6 | 125.6 | GO:0045182 | translation regulator activity(GO:0045182) |
3.6 | 32.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
3.6 | 10.7 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
3.6 | 21.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
3.6 | 21.4 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
3.6 | 24.9 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
3.5 | 102.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
3.5 | 21.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
3.5 | 17.7 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
3.5 | 3.5 | GO:0032564 | dATP binding(GO:0032564) |
3.5 | 42.1 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
3.5 | 66.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
3.5 | 10.4 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
3.4 | 48.1 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
3.4 | 58.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
3.4 | 101.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
3.3 | 23.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
3.3 | 6.6 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
3.3 | 6.5 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
3.2 | 16.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
3.2 | 9.7 | GO:0048039 | ubiquinone binding(GO:0048039) |
3.2 | 38.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
3.2 | 31.9 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
3.2 | 12.7 | GO:0034431 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
3.2 | 82.1 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
3.1 | 31.4 | GO:0001846 | opsonin binding(GO:0001846) |
3.1 | 15.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
3.1 | 18.7 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
3.1 | 15.6 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
3.1 | 140.2 | GO:0019213 | deacetylase activity(GO:0019213) |
3.1 | 15.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
3.1 | 9.3 | GO:0031208 | POZ domain binding(GO:0031208) |
3.1 | 89.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
3.0 | 3.0 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
3.0 | 20.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
2.9 | 2.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
2.9 | 8.8 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
2.9 | 8.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.9 | 11.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
2.9 | 11.6 | GO:0050682 | AF-2 domain binding(GO:0050682) |
2.9 | 14.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
2.9 | 8.6 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
2.9 | 31.5 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
2.8 | 5.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
2.8 | 22.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
2.8 | 14.1 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
2.8 | 11.2 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
2.8 | 11.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
2.8 | 13.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
2.8 | 11.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
2.7 | 27.3 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
2.7 | 37.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
2.7 | 67.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
2.7 | 8.0 | GO:0005534 | galactose binding(GO:0005534) |
2.7 | 80.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
2.7 | 8.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
2.6 | 26.5 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
2.6 | 26.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
2.6 | 10.4 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
2.6 | 10.3 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
2.6 | 61.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
2.6 | 7.7 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
2.5 | 7.6 | GO:0030984 | kininogen binding(GO:0030984) |
2.5 | 25.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
2.5 | 7.6 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
2.5 | 5.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
2.5 | 12.5 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
2.5 | 22.2 | GO:0098879 | structural constituent of postsynaptic specialization(GO:0098879) structural constituent of postsynaptic density(GO:0098919) |
2.4 | 19.6 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
2.4 | 34.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
2.4 | 7.2 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
2.4 | 16.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
2.4 | 7.1 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
2.4 | 28.6 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
2.4 | 11.9 | GO:0097016 | L27 domain binding(GO:0097016) |
2.4 | 7.1 | GO:0003921 | GMP synthase activity(GO:0003921) GMP synthase (glutamine-hydrolyzing) activity(GO:0003922) |
2.4 | 11.8 | GO:0046790 | virion binding(GO:0046790) |
2.4 | 7.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
2.3 | 14.1 | GO:0031014 | troponin T binding(GO:0031014) |
2.3 | 2.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
2.3 | 4.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
2.3 | 7.0 | GO:0098821 | BMP receptor activity(GO:0098821) |
2.3 | 7.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
2.3 | 34.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
2.3 | 13.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
2.3 | 16.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
2.3 | 4.5 | GO:0030957 | Tat protein binding(GO:0030957) |
2.3 | 15.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
2.2 | 13.5 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
2.2 | 11.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.2 | 9.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
2.2 | 11.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
2.2 | 64.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
2.2 | 52.9 | GO:0030332 | cyclin binding(GO:0030332) |
2.2 | 11.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
2.2 | 6.6 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
2.2 | 10.9 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
2.2 | 13.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
2.2 | 10.8 | GO:0032052 | bile acid binding(GO:0032052) |
2.2 | 17.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
2.1 | 4.3 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
2.1 | 17.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
2.1 | 8.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
2.1 | 55.3 | GO:0070001 | aspartic-type peptidase activity(GO:0070001) |
2.1 | 6.4 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
2.1 | 4.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
2.1 | 4.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
2.1 | 10.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
2.0 | 6.1 | GO:0031783 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
2.0 | 14.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
2.0 | 7.9 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
1.9 | 412.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
1.9 | 19.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
1.9 | 44.4 | GO:0050661 | NADP binding(GO:0050661) |
1.9 | 38.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
1.9 | 5.7 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
1.9 | 5.7 | GO:0004946 | bombesin receptor activity(GO:0004946) |
1.9 | 3.8 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.9 | 29.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
1.9 | 20.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
1.9 | 9.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
1.8 | 20.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
1.8 | 5.5 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
1.8 | 61.7 | GO:0030506 | ankyrin binding(GO:0030506) |
1.8 | 21.7 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
1.8 | 10.7 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
1.7 | 14.0 | GO:0001848 | complement binding(GO:0001848) |
1.7 | 7.0 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
1.7 | 10.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.7 | 13.8 | GO:0030983 | mismatched DNA binding(GO:0030983) |
1.7 | 12.0 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) |
1.7 | 22.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
1.7 | 10.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.7 | 8.4 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
1.7 | 8.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.7 | 193.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.7 | 6.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.7 | 25.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
1.7 | 80.1 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
1.7 | 9.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.7 | 44.6 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
1.6 | 32.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.6 | 9.8 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.6 | 11.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.6 | 103.4 | GO:0005496 | steroid binding(GO:0005496) |
1.6 | 9.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
1.6 | 4.8 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
1.6 | 37.9 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
1.5 | 20.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
1.5 | 10.8 | GO:0045545 | syndecan binding(GO:0045545) |
1.5 | 6.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
1.5 | 19.8 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
1.5 | 6.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.5 | 4.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.5 | 1.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.5 | 26.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
1.5 | 11.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
1.5 | 19.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.5 | 22.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
1.5 | 33.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
1.4 | 5.7 | GO:0000829 | inositol heptakisphosphate kinase activity(GO:0000829) |
1.4 | 14.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
1.4 | 2.8 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
1.4 | 4.2 | GO:0004586 | ornithine decarboxylase activity(GO:0004586) |
1.4 | 2.8 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
1.4 | 9.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
1.4 | 19.5 | GO:0008199 | ferric iron binding(GO:0008199) |
1.4 | 5.6 | GO:0035198 | miRNA binding(GO:0035198) |
1.4 | 8.3 | GO:0070728 | leucine binding(GO:0070728) |
1.4 | 44.3 | GO:0016836 | hydro-lyase activity(GO:0016836) |
1.4 | 17.9 | GO:0001222 | transcription corepressor binding(GO:0001222) |
1.4 | 5.5 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
1.4 | 19.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
1.4 | 12.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
1.4 | 17.6 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
1.3 | 9.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.3 | 9.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
1.3 | 35.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
1.3 | 6.7 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.3 | 17.4 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
1.3 | 13.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
1.3 | 4.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
1.3 | 6.7 | GO:0033265 | choline binding(GO:0033265) |
1.3 | 7.9 | GO:0004659 | prenyltransferase activity(GO:0004659) |
1.3 | 9.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
1.3 | 22.2 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
1.3 | 38.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.3 | 10.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
1.3 | 6.3 | GO:0005550 | pheromone binding(GO:0005550) |
1.3 | 8.8 | GO:0008061 | chitin binding(GO:0008061) |
1.3 | 20.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
1.2 | 40.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.2 | 3.7 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
1.2 | 1.2 | GO:0043559 | insulin binding(GO:0043559) |
1.2 | 4.9 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) corticotropin-releasing hormone receptor activity(GO:0043404) |
1.2 | 3.6 | GO:0004064 | arylesterase activity(GO:0004064) |
1.2 | 2.4 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
1.2 | 14.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
1.2 | 4.7 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.2 | 15.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.2 | 2.3 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
1.2 | 1.2 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
1.1 | 17.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.1 | 9.1 | GO:0043495 | protein anchor(GO:0043495) |
1.1 | 18.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
1.1 | 25.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
1.1 | 10.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
1.1 | 10.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
1.1 | 21.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.1 | 67.8 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
1.1 | 7.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.1 | 3.3 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
1.1 | 18.5 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
1.1 | 79.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
1.1 | 18.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.1 | 11.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
1.1 | 4.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
1.0 | 24.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.0 | 4.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.0 | 5.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.0 | 1.0 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
1.0 | 3.1 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
1.0 | 8.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.0 | 7.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.0 | 14.8 | GO:0031996 | thioesterase binding(GO:0031996) |
1.0 | 4.8 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
1.0 | 5.8 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.9 | 2.8 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.9 | 12.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.9 | 3.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.9 | 80.1 | GO:0101005 | ubiquitinyl hydrolase activity(GO:0101005) |
0.9 | 8.4 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.9 | 5.5 | GO:0042285 | xylosyltransferase activity(GO:0042285) |
0.9 | 12.9 | GO:0070840 | dynein complex binding(GO:0070840) |
0.9 | 11.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.9 | 7.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.9 | 3.6 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.9 | 3.6 | GO:0002046 | opsin binding(GO:0002046) |
0.9 | 4.5 | GO:0071253 | connexin binding(GO:0071253) |
0.9 | 19.5 | GO:0051287 | NAD binding(GO:0051287) |
0.9 | 3.5 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.9 | 22.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.9 | 5.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.9 | 33.8 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.9 | 5.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.9 | 8.6 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.9 | 21.5 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.8 | 3.4 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.8 | 5.9 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.8 | 3.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.8 | 3.3 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.8 | 17.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.8 | 3.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.8 | 4.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.8 | 7.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.8 | 8.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.8 | 3.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.8 | 3.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.8 | 12.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.8 | 1.5 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.8 | 30.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.8 | 16.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.8 | 2.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.7 | 3.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.7 | 11.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.7 | 9.6 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.7 | 16.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.7 | 1.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.7 | 8.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.7 | 5.8 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.7 | 5.8 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.7 | 23.9 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.7 | 3.6 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.7 | 2.2 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.7 | 9.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.7 | 10.3 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.7 | 114.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.7 | 1.4 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.7 | 3.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.7 | 18.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.7 | 3.3 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
0.6 | 8.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.6 | 16.0 | GO:0009975 | cyclase activity(GO:0009975) |
0.6 | 5.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.6 | 16.8 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.6 | 97.9 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.6 | 4.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.6 | 3.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.6 | 1.8 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.6 | 8.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.6 | 2.3 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.6 | 2.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.6 | 2.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.6 | 8.0 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.6 | 1.7 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.6 | 4.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.6 | 7.4 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.6 | 2.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.6 | 1.7 | GO:0030977 | taurine binding(GO:0030977) |
0.6 | 7.8 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.6 | 1.7 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.5 | 6.0 | GO:0070513 | death domain binding(GO:0070513) |
0.5 | 19.0 | GO:0004620 | phospholipase activity(GO:0004620) |
0.5 | 6.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.5 | 1.5 | GO:0001605 | adrenomedullin receptor activity(GO:0001605) |
0.5 | 1.5 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.5 | 8.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.5 | 4.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.5 | 3.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.5 | 3.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.5 | 6.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.5 | 17.1 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.5 | 14.6 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.5 | 29.4 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.5 | 11.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.5 | 3.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.5 | 1.8 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.4 | 2.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.4 | 32.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.4 | 12.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.4 | 1.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.4 | 1.6 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.4 | 2.5 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.4 | 8.2 | GO:0016896 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.4 | 0.8 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.4 | 1.6 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.4 | 16.4 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.4 | 1.9 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.4 | 1.9 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.4 | 3.4 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.4 | 15.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.4 | 0.4 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 5.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.4 | 9.6 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.3 | 1.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.3 | 5.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.3 | 1.9 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.3 | 0.6 | GO:0001635 | calcitonin gene-related peptide receptor activity(GO:0001635) |
0.3 | 42.7 | GO:0005179 | hormone activity(GO:0005179) |
0.3 | 34.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.3 | 4.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 1.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 3.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 2.9 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.3 | 71.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.3 | 1.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.3 | 0.8 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.3 | 3.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.3 | 2.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 1.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 3.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 8.9 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 29.7 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.2 | 10.9 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.2 | 14.7 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.2 | 0.5 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.2 | 0.4 | GO:0098918 | structural constituent of synapse(GO:0098918) |
0.2 | 1.3 | GO:0005549 | odorant binding(GO:0005549) |
0.2 | 1.6 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 0.8 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.2 | 1.0 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 60.9 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) |
0.2 | 2.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 1.5 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 156.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 0.2 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.1 | 4.0 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.1 | 0.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 35.3 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.7 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.5 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.2 | GO:0000991 | transcription factor activity, core RNA polymerase II binding(GO:0000991) |
0.1 | 0.8 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.2 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.1 | 1.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 7.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.7 | 6.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
5.2 | 10.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
5.1 | 280.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
3.4 | 72.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
3.3 | 13.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
3.0 | 12.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
2.6 | 55.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
2.3 | 66.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
2.2 | 12.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
2.1 | 60.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
2.0 | 89.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
2.0 | 90.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
1.9 | 39.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.7 | 7.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.4 | 18.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
1.4 | 35.4 | PID ALK1 PATHWAY | ALK1 signaling events |
1.4 | 21.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
1.4 | 25.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
1.4 | 48.7 | PID AURORA A PATHWAY | Aurora A signaling |
1.4 | 36.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.4 | 27.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.3 | 8.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.3 | 34.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
1.3 | 67.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
1.2 | 9.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.2 | 25.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
1.1 | 55.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
1.1 | 5.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
1.1 | 19.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
1.1 | 7.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.0 | 24.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
1.0 | 12.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.9 | 9.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.7 | 22.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.7 | 45.4 | PID E2F PATHWAY | E2F transcription factor network |
0.7 | 17.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.7 | 23.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.6 | 5.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.6 | 4.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.6 | 145.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.6 | 27.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.5 | 20.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.5 | 2.9 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.5 | 2.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.5 | 1.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.4 | 5.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 4.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.4 | 6.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.4 | 6.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 0.6 | ST ADRENERGIC | Adrenergic Pathway |
0.3 | 3.9 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 3.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 64.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 0.8 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 8.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 2.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 0.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
23.4 | 210.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
17.8 | 248.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
15.9 | 190.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
14.9 | 119.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
14.1 | 254.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
13.8 | 398.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
13.4 | 133.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
13.0 | 221.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
11.4 | 113.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
11.2 | 258.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
9.6 | 115.2 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
8.8 | 123.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
8.0 | 135.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
7.9 | 1038.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
7.9 | 94.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
7.6 | 22.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
7.5 | 89.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
6.9 | 137.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
6.8 | 88.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
6.8 | 6.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
6.4 | 173.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
6.1 | 103.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
5.7 | 68.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
5.5 | 219.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
5.0 | 5.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
4.9 | 9.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
4.9 | 4.9 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
4.8 | 48.4 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
4.8 | 72.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
4.6 | 13.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
4.5 | 170.0 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
4.4 | 88.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
4.4 | 157.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
4.3 | 64.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
4.3 | 123.8 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
4.1 | 45.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
4.0 | 167.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
4.0 | 23.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
4.0 | 31.6 | REACTOME OPSINS | Genes involved in Opsins |
3.8 | 72.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
3.8 | 41.8 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
3.7 | 59.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
3.6 | 50.6 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
3.5 | 38.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
3.5 | 24.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
3.4 | 37.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
3.3 | 52.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
3.3 | 78.1 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
3.1 | 55.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
3.1 | 30.9 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
3.1 | 43.0 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
3.1 | 45.9 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
2.8 | 56.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
2.8 | 39.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
2.8 | 108.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
2.8 | 57.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
2.7 | 30.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
2.5 | 53.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
2.5 | 53.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
2.5 | 5.1 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
2.5 | 47.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
2.5 | 27.5 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
2.5 | 32.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
2.5 | 14.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
2.5 | 81.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
2.5 | 36.8 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
2.4 | 2.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
2.4 | 50.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
2.4 | 2.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
2.3 | 32.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
2.3 | 18.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
2.3 | 22.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
2.2 | 22.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
2.2 | 28.6 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
2.2 | 10.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
2.2 | 86.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
2.1 | 58.9 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
2.1 | 43.6 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
2.1 | 24.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
2.0 | 22.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
1.9 | 25.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.9 | 16.8 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
1.9 | 77.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
1.8 | 43.6 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
1.8 | 41.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
1.8 | 5.4 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
1.6 | 19.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
1.6 | 6.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.6 | 28.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
1.6 | 62.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
1.5 | 95.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
1.5 | 11.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
1.5 | 88.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
1.5 | 18.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
1.5 | 2.9 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
1.4 | 45.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
1.4 | 8.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
1.4 | 10.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.4 | 10.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
1.3 | 4.0 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
1.3 | 18.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
1.3 | 16.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.2 | 53.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.2 | 4.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
1.2 | 16.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
1.2 | 86.7 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
1.2 | 9.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
1.2 | 3.5 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
1.1 | 11.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.1 | 15.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.1 | 36.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
1.0 | 164.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
1.0 | 15.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
1.0 | 2.9 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.9 | 45.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.9 | 2.8 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.8 | 2.5 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.8 | 42.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.8 | 17.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.8 | 21.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.7 | 6.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.7 | 8.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.7 | 12.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.7 | 12.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.7 | 12.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.6 | 13.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.6 | 2.5 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.6 | 19.1 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.6 | 2.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.6 | 6.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.5 | 13.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 12.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.4 | 7.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 2.0 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 6.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.3 | 3.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 6.1 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.2 | 4.6 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.2 | 1.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 3.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 0.6 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.1 | 8.5 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 1.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 1.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |